Dysphagia

R18_DYSPHAGIA

agnosia: A rare disorder characterized by the lack of ability to recognize individuals, objects, shapes, sounds, or smells. There is no loss of memory. It is caused by neurological damage in the brain, specifically in the occipital or parietal lobes.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R13 Hospital discharge: ICD-9 — 7872 Cause of death: ICD-10 — R13 Cause of death: ICD-9 — 7872 2 out of 7 registries used, show all original rules.	12372
4. Check minimum number of events None	12372
5. Include endpoints None	12372
6. Filter based on genotype QC (FinnGen only)	11977

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_DIGES_SYSTEM_ABDOMEN

Extra metadata

Level in the ICD hierarchy: 3
Special: APHADYSPHAGIA
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R10-R19
Name in latin: Dysphagia

NAME	R18_DYSPHAGIA
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_DIGES_SYSTEM_ABDOMEN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R13
HD_ICD_9	7872
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R13
COD_ICD_9	7872
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dysphagia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11977	6534	5443
Unadjusted period prevalence (%)	2.40	2.32	2.49
Median age at first event (years)	64.58	61.18	68.66

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12371: Matched controls
123710

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A06AD11

ATC

lactulose; oral

2.6

318.1

2180

9379

R03AC02

ATC

salbutamol; inhalant

2.0

317.5

6817

46450

K59.09

ICD-10 Finland

Constipation, unspecified

3.7

316.7

1064

3038

H02AB06

ATC

prednisolone; systemic

2.0

316.6

6189

40766

P01AB01

ATC

metronidazole; oral, rectal

2.1

316.2

4783

28703

D01

ICPC

Abdominal pain/cramps general

3.2

313.5

1390

4732

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

2187

8752

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

+∞

307.7

312

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

307.7

6487

39148

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.0

307.7

1433

3925

JN3AD

NOMESCO Finland

Abdominal CT examination

3.4

307.7

1489

4732

A02BC02

ATC

pantoprazole; systemic

3.5

307.7

9572

61480

N06AX11

ATC

mirtazapine; oral

2.3

307.7

4550

25204

A02BC05

ATC

esomeprazole; systemic

3.5

307.7

6534

29794

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

4.9

307.7

2112

5033

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.8

307.7

1090

3035

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

21.6

307.7

773

380

Z01.8

ICD-10 Finland

Other specified special examinations

2.5

307.7

3319

15569

R06.0

ICD-10 Finland

Dyspnoea

2.6

307.7

4083

19482

AA1AD

NOMESCO Finland

CT of head and brain

2.3

307.7

4047

21414

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

307.7

4130

19252

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

10.0

307.7

5169

8289

UJC02

NOMESCO Finland

Rigid oesophagoscopy

45.3

307.7

604

140

T18.1

ICD-10 Finland

Foreign body in oesophagus

14.5

307.7

349

248

N06AX21

ATC

duloxetine; oral

3.4

307.7

1749

5707

UJC12

NOMESCO Finland

Flexible oesophagoscopy

36.3

307.7

489

140

UDQ12

NOMESCO Finland

Flexible laryngoscopy

9.1

307.7

1997

2567

R4130

NOMESCO Finland

Speech therapy

8.5

307.7

831

1037

D21

ICPC

Swallowing problem

16.5

307.7

752

484

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

307.7

3686

17561

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

5.7

307.7

2918

6385

A02BC04

ATC

rabeprazole; oral

3.4

307.7

1286

4075

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

35.5

307.7

704

210

R13

ICD-10 Finland

Dysphagia

14196.0

307.7

12250

876

M54.5

ICD-10 Finland

Low back pain

2.1

307.7

4437

25573

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

34.9

307.7

402

119

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

8.4

307.7

7086

17056

A02BC01

ATC

omeprazole; systemic

2.5

307.7

3913

19273

N03AX12

ATC

[U] gabapentin; oral

3.0

307.7

2491

9706

K30

ICD-10 Finland

Functional dyspepsia

3.5

307.7

1589

5059

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

+∞

307.7

597

A02BC03

ATC

lansoprazole; oral

2.6

307.7

4241

20392

R53

ICD-10 Finland

Malaise and fatigue

2.5

307.7

3406

16086

R42

ICD-10 Finland

Dizziness and giddiness

2.4

307.7

3321

16476

R51.80

ICD-10 Finland

Headache

3.5

307.7

2221

7237

TJD20

NOMESCO Finland

Change of gastrostomy tube

35.3

307.7

259

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

5677

33980

UJF32

NOMESCO Finland

Coloscopy

2.9

307.7

3836

16555

K22.2

ICD-10 Finland

Oesophageal obstruction

24.2

307.7

524

226

UJD02

NOMESCO Finland

Gastroscopy

6.6

307.7

1041

1686

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

5.0

307.7

2054

4698

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

42.6

307.7

647

160

R11

ICD-10 Finland

Nausea and vomiting

8.7

307.7

1227

1553

N03AX16

ATC

[U] pregabalin

2.9

307.7

3555

15124

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

143.6

307.7

1368

107

UDH02

NOMESCO Finland

Rhinopharyngoscopy

4.1

307.7

1226

3253

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

307.7

3598

18368

R10.1

ICD-10 Finland

Pain localized to upper abdomen

6.1

307.7

2509

4965

UJC01

NOMESCO Finland

Scopy of lower throat

16.0

307.7

454

293

R07.0

ICD-10 Finland

Pain in throat

4.2

307.7

1157

2948

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

10.7

307.7

438

421

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.9

307.7

1321

3692

JDB10

NOMESCO Finland

Percutaneous gastrostomy

21.7

307.7

737

360

R15

ICD-10 Finland

Faecal incontinence

10.9

307.7

355

334

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

36.1

307.7

213

G44.2

ICD-10 Finland

Tension-type headache

3.0

307.7

1816

6785

R47.1

ICD-10 Finland

Dysarthria and anarthria

18.5

307.7

455

255

A02BA02

ATC

ranitidine; systemic

2.6

307.7

2743

12359

K22.0

ICD-10 Finland

Achalasia of cardia

25.3

306.1

214

J37.0

ICD-10 Finland

Chronic laryngitis

5.1

301.4

655

1338

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.2

299.6

1311

4423

M79.6

ICD-10 Finland

Pain in limb

2.0

297.2

5206

32755

Z50.5

ICD-10 Finland

Speech therapy

8.9

295.3

373

433

K22.5

ICD-10 Finland

Diverticulum of oesophagus, acquired

20.8

295.1

223

109

A03FA01

ATC

metoclopramide; systemic, rectal

2.3

293.9

2878

14493

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

293.5

1689

6636

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.4

292.6

2442

11476

R12

ICD-10 Finland

Heartburn

3.5

292.5

1073

3243

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

283.1

2943

15162

N06AA09

ATC

amitriptyline; systemic

2.9

274.7

1398

5133

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.7

274.6

1749

7222

N02AA05

ATC

oxycodone; systemic

2.3

271.5

2466

11985

R21

ICPC

Throat symptom/complaint

2.3

271.0

2443

11834

N05BA04

ATC

oxazepam; oral

2.1

269.7

3338

18367

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

268.1

2114

9651

R4190

NOMESCO Finland

Nutritional therapy

4.7

267.9

640

1414

R10.0

ICD-10 Finland

Acute abdomen

9.1

267.4

329

369

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.9

266.9

816

2176

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

7.3

265.6

396

559

R07.3

ICD-10 Finland

Other chest pain

2.9

264.0

1392

5205

A07AA02

ATC

nystatin; oral

3.4

263.7

998

3072

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.1

259.7

737

1861

J02AC01

ATC

fluconazole; systemic

2.0

259.0

4633

29000

R52.2

ICD-10 Finland

Other chronic pain

4.9

258.6

586

1239

UKC02

NOMESCO Finland

Cystoscopy

2.3

258.5

2298

11044

N05CF01

ATC

zopiclone; oral

2.0

254.2

4197

25526

N03AE01

ATC

clonazepam; systemic

3.5

251.3

907

2706

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

247.6

3492

20062

L28

ICPC

Limited function/disability (L)

2.2

246.1

2575

13210

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

246.0

2560

13105

N06AX16

ATC

venlafaxine; oral

2.5

242.3

1697

7310

A03FA02

ATC

cisapride; oral, rectal

3.1

241.7

1092

3738

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

241.1

1398

5485

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

20.5

239.5

182

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

15.0

238.2

211

143

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

237.9

1479

6009

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

236.7

2467

12616

J01DB01

ATC

cefalexin; oral

2.1

234.6

10023

82387

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.8

233.9

1271

4817

J01MA02

ATC

ciprofloxacin; systemic

1.9

233.6

4819

31343

N05AH04

ATC

quetiapine; oral

2.3

233.2

2109

10169

A01

ICPC

Pain general/multiple sites

2.8

231.4

1269

4832

M54.4

ICD-10 Finland

Lumbago with sciatica

2.3

231.3

2184

10719

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

6.2

229.7

399

661

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

228.5

5366

36279

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

227.7

5054

33563

R52.9

ICD-10 Finland

Pain, unspecified

2.8

227.7

1306

5089

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.3

227.5

614

1491

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.6

226.4

437

801

N02BE01

ATC

paracetamol; systemic, rectal

2.5

226.2

10957

93766

K59.0

ICD-10 Finland

Constipation

3.5

225.6

832

2513

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

224.6

2332

11881

R05

ICD-10 Finland

Cough

2.1

224.6

2784

15180

UJF30

NOMESCO Finland

Ileoscopy through colon

2.7

224.0

1325

5243

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

223.8

3472

20499

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

5.2

221.8

470

937

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

221.0

4460

28678

N05BA01

ATC

diazepam; systemic, rectal

2.4

218.9

1731

7859

Z3226

NOMESCO Finland

Physiotherapist

2.1

218.3

2455

12888

R02

ICPC

Shortness of breath/dyspnoea

2.4

217.9

1784

8224

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

216.7

1040

3678

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

214.9

3692

22500

H04.10

ICD-10 Finland

Dry eye syndrome

2.5

211.8

1535

6693

N06AB04

ATC

citalopram; systemic

2.1

211.6

2578

13931

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

211.4

2338

12180

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

12.4

211.4

209

171

D06

ICPC

Abdominal pain localized other

3.0

211.2

997

3492

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.6

209.8

736

2150

M25.5

ICD-10 Finland

Pain in joint

1.9

208.2

3706

22802

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

207.3

950

3270

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

206.1

2317

12134

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.2

205.4

571

1417

SPAT1263

SPAT

Sampling

1.8

203.6

5066

34496

M79.1

ICD-10 Finland

Myalgia

2.3

202.5

1723

8059

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

201.7

1030

3765

M03BX02

ATC

tizanidine; oral

1.8

201.1

7047

52908

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.7

200.3

1201

4774

F45.8

ICD-10 Finland

Other somatoform disorders

3.2

199.5

843

2766

XJC00

NOMESCO Finland

Oesophageal manometry

22.4

199.4

146

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

197.6

1449

6342

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

196.4

5436

38061

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

195.6

1766

8462

J01MA12

ATC

levofloxacin; systemic

2.1

195.4

2346

12567

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.5

194.0

490

1129

R20.2

ICD-10 Finland

Paraesthesia of skin

3.0

194.0

934

3303

L03

ICPC

Low back symptom/complaint

1.9

193.5

3220

19306

A04

ICPC

Weakness/tiredness general

2.2

191.7

1886

9353

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

190.1

5996

43426

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

189.6

1713

8202

R01AD09

ATC

mometasone; nasal

1.8

189.4

5136

35636

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

188.8

1327

5690

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

188.6

2202

11659

S18

ICPC

Laceration/cut

1.7

188.2

5657

40384

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

187.6

1113

4395

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

187.4

1939

9802

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

187.2

1311

5610

L01

ICPC

Neck symptom/complaint

2.2

186.1

1878

9400

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

185.7

8252

65590

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

185.4

4822

33009

ZXD05

NOMESCO Finland

Urgent procedure

1.8

185.0

3526

22017

D02

ICPC

Abdominal pain epigastric

3.4

183.7

701

2159

A11

ICPC

Chest pain NOS

2.6

183.3

1118

4475

K20

ICD-10 Finland

Oesophagitis

6.0

182.3

326

555

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

181.7

3392

21023

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

179.9

3922

25458

M79.7

ICD-10 Finland

Fibromyalgia

4.4

178.7

457

1063

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

178.4

2454

13753

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

3.2

177.3

747

2443

R49.08

ICD-10 Finland

Other specified dysphonia

4.8

175.7

408

878

G12.2

ICD-10 Finland

Motor neuron disease

10.1

175.1

198

C07AB07

ATC

bisoprolol; oral

1.7

175.1

6140

45399

R49.01

ICD-10 Finland

Functional dysphonia

4.0

174.5

507

1298

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

174.4

4972

34753

G47.3

ICD-10 Finland

Sleep apnoea

1.9

173.7

2705

15788

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

172.4

1382

6274

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

5.7

172.1

327

590

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

172.1

8132

65016

WX002

NOMESCO Finland

Sedation and analgesia

1.9

172.0

2508

14316

M48.0

ICD-10 Finland

Spinal stenosis

2.2

172.0

1708

8475

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

170.6

2000

10570

K22.8

ICD-10 Finland

Other specified diseases of oesophagus

19.8

169.7

131

N01

ICPC

Headache

2.5

169.6

1150

4838

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

168.6

2296

12794

R10.2

ICD-10 Finland

Pelvic and perineal pain

7.4

167.6

243

332

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

167.2

2533

14627

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

167.0

2430

13846

C07AA05

ATC

propranolol; systemic

2.0

166.4

2285

12763

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

166.4

3002

18329

J01AA02

ATC

doxycycline; systemic

1.8

166.1

9245

76969

M54.2

ICD-10 Finland

Cervicalgia

2.7

166.1

967

3775

A01AB09

ATC

miconazole; local oral

2.5

165.9

1165

4980

Z43.1

ICD-10 Finland

Attention to gastrostomy

34.2

165.7

105

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.3

165.1

642

1998

JCA98

NOMESCO Finland

Other local endoscopic operation on oesophagus

29.7

164.9

109

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

164.9

1014

4068

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

9.5

163.6

194

207

SPAT1301

SPAT

No procedures

1.7

161.3

3861

25577

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

161.3

998

4015

M54.6

ICD-10 Finland

Pain in thoracic spine

2.8

161.2

878

3311

R35

ICD-10 Finland

Polyuria

2.7

161.0

940

3673

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

5.7

160.1

302

541

N06AB10

ATC

escitalopram; oral

2.0

159.7

2183

12158

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

159.6

3132

19579

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

159.2

4371

30041

N03AX09

ATC

lamotrigine; oral

3.6

159.2

555

1611

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

159.0

5238

37768

R03BB04

ATC

tiotropium bromide; inhalant

2.3

158.4

1412

6694

R50.9

ICD-10 Finland

Fever, unspecified

2.1

158.1

1762

9118

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

157.6

6236

47086

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.2

157.6

1587

7900

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

157.2

2068

11359

J01FA06

ATC

roxithromycin; oral

1.7

156.2

4594

32117

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

155.8

4208

28754

R63.4

ICD-10 Finland

Abnormal weight loss

3.4

155.1

579

1756

K07.60

ICD-10 Finland

Snapping jaw

3.3

155.1

598

1851

ZXE00

NOMESCO Finland

One hour or less

1.7

154.1

4532

31652

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

153.9

1006

4153

7872A

ICD-9 Finland

Symptoms involving digestive system, Dysphagia

+∞

153.4

147

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.7

153.0

246

376

J01CA04

ATC

amoxicillin; systemic

1.8

152.8

9522

80657

JAH01

NOMESCO Finland

Laparoscopy

4.1

151.6

435

1103

SPAT1254

SPAT

Administration of medicine

2.0

150.6

1879

10119

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.6

149.8

516

1485

GBB00

NOMESCO Finland

Tracheostomy

6.0

149.2

268

458

J01EA01

ATC

trimethoprim; systemic

1.8

149.1

3040

19159

L17

ICPC

Foot/toe symptom/complaint

1.7

148.8

3418

22282

JCA08

NOMESCO Finland

Endoscopic removal of foreign body from oesophagus

21.8

148.6

110

N30.0

ICD-10 Finland

Acute cystitis

2.0

148.2

1888

10236

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

148.2

1185

5358

Z3231

NOMESCO Finland

Registered nurse

1.7

148.1

3330

21574

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

148.1

4331

30124

A03CA02

ATC

clidinium and psycholeptics; oral

2.9

147.7

740

2666

JDB00

NOMESCO Finland

Gastrostomy

42.2

146.8

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.7

146.5

842

3260

A28

ICPC

Limited function/disability NOS

1.9

146.4

2292

13312

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.1

146.2

646

2169

R51

ICD-10 Finland

Headache

3.1

145.8

629

2082

J01DA01

ATC

[U] cefalexin

1.6

145.6

7110

56108

R18

ICD-10 Finland

Ascites

18.7

145.5

115

R01AD08

ATC

fluticasone; nasal

1.7

143.9

3163

20334

N02BF01

ATC

gabapentin; oral

2.5

143.6

998

4236

R03DC03

ATC

montelukast; oral

2.0

143.3

1878

10274

SPAT1229

SPAT

Assessment of need for aid

2.4

143.3

1120

5012

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

143.2

2863

17908

J01FF01

ATC

clindamycin; systemic

1.7

142.4

3128

20096

M03BX01

ATC

baclofen; systemic

4.9

142.0

315

652

N02BF02

ATC

pregabalin; oral

2.8

140.7

725

2651

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

140.3

1270

6044

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

139.7

2369

14090

R06AE07

ATC

cetirizine; oral

1.6

139.3

4887

35447

C03CA01

ATC

furosemide; systemic

1.7

139.0

3826

26097

Z01.2

ICD-10 Finland

Dental examination

1.6

138.4

5016

36655

M01AE02

ATC

naproxen; oral, rectal

1.6

138.3

6272

48361

R00.2

ICD-10 Finland

Palpitations

2.5

138.0

909

3761

H03AA01

ATC

levothyroxine sodium; systemic

1.8

137.9

2824

17760

R51.81

ICD-10 Finland

Facial pain NOS

4.6

137.1

334

747

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

136.6

836

3337

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

136.6

873

3559

SPAT1240

SPAT

Therapeutic discussion

2.3

136.3

1081

4864

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

135.6

4181

29315

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

135.4

1433

7245

R03BA05

ATC

fluticasone; inhalant

1.9

135.4

2099

12122

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

12.2

135.3

135

112

N04BC05

ATC

pramipexole; oral

2.4

134.5

1025

4531

S06.0

ICD-10 Finland

Concussion

2.2

134.1

1275

6184

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.2

133.9

1261

6092

WX402

NOMESCO Finland

General anaesthesia

1.8

131.8

2368

14306

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

131.2

1449

7439

SPAT1216

SPAT

Assessment of functional ability

1.9

131.0

2056

11909

A06AC51

ATC

ispaghula, combinations; oral

3.0

130.8

615

2137

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

130.3

630

2224

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

129.8

885

3718

H02AB04

ATC

methylprednisolone; systemic

2.0

129.5

1714

9383

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.3

129.4

1020

4574

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

128.6

7297

58855

R03BA02

ATC

budesonide; inhalant

1.9

128.6

2068

12064

Z2446

NOMESCO Finland

Social worker

2.6

128.1

785

3134

N06AB06

ATC

sertraline; oral

2.2

128.1

1205

5815

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

127.7

1930

11037

K59.1

ICD-10 Finland

Functional diarrhoea

2.8

127.5

669

2468

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

126.8

802

3251

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

126.6

1535

8147

N17

ICPC

Vertigo/dizziness

2.0

126.3

1513

7995

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.6

126.2

757

2990

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

126.2

1678

9195

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

126.0

976

4341

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.5

125.6

872

3693

K02.1

ICD-10 Finland

Caries of dentine

1.6

125.4

6354

49812

R05

ICPC

Cough

1.7

125.4

2713

17261

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

125.2

713

2743

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

125.1

2404

14787

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

124.9

1027

4687

XF402

NOMESCO Finland

ECG with work load test

2.1

124.4

1339

6802

SPAT1153

SPAT

Removal of sutures

1.6

123.9

3779

26293

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

123.6

980

4403

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

123.5

669

2508

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

123.3

4440

32143

TAB00

NOMESCO Finland

Lumbar puncture

3.0

123.3

577

1999

R4110

NOMESCO Finland

Physiotherapy

1.7

123.2

3271

21968

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

122.9

2917

19020

1320

FHL

Esophagoscopy

13.5

122.7

115

J01FA10

ATC

azithromycin; systemic

1.6

122.4

6121

47740

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

122.4

1409

7334

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

120.8

983

4464

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.2

120.6

1129

5432

R60.0

ICD-10 Finland

Localized oedema

2.0

120.5

1549

8380

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

118.4

1529

8282

H02AB07

ATC

prednisone; oral

1.9

118.4

1657

9222

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

118.3

563

1968

Z93.1

ICD-10 Finland

Gastrostomy status

65.3

118.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

118.1

1025

4781

J01MA14

ATC

moxifloxacin; systemic

2.2

117.7

1085

5186

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

5.3

117.7

239

458

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.2

117.6

1070

5088

G50.1

ICD-10 Finland

Atypical facial pain

5.0

117.2

255

519

E0000UV, ,

ATC

1.6

117.0

4708

34856

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

4.3

117.0

304

715

UDC00

NOMESCO Finland

Ear microscopy

2.3

116.3

970

4449

R03BA08

ATC

ciclesonide; inhalant

2.2

116.0

1019

4775

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

116.0

1713

9699

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

115.5

571

2038

SFA10

NOMESCO Finland

One-surface restoration

1.5

115.4

5967

46649

Z71.8

ICD-10 Finland

Other specified counselling

1.6

115.0

3350

22960

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

114.8

1016

4775

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.7

114.4

369

1015

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

114.4

1134

5575

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.9

114.2

547

1919

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.4

113.7

426

1293

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.0

113.4

517

1764

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.0

112.8

509

1727

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

112.3

1376

7311

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

8.8

112.0

140

160

R55

ICD-10 Finland

Syncope and collapse

2.0

111.9

1392

7435

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

111.8

1691

9640

Z2221

NOMESCO Finland

Medical doctor

1.6

111.7

3118

21117

G43.9

ICD-10 Finland

Migraine, unspecified

2.9

111.5

537

1889

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.3

111.2

424

1301

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

111.1

1106

5443

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.6

110.9

378

1079

K08.80

ICD-10 Finland

Toothache NOS

2.3

110.7

924

4237

L08

ICPC

Shoulder symptom/complaint

1.7

110.3

2466

15758

R01AD58

ATC

fluticasone, combinations; nasal

1.7

110.0

2416

15363

SPAT1260

SPAT

Consultation of another employee

1.8

109.8

2078

12673

K29.7

ICD-10 Finland

Gastritis, unspecified

3.2

108.8

436

1379

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

108.8

2389

15187

R01AD12

ATC

fluticasone furoate; nasal

1.6

108.6

3159

21589

N06AB03

ATC

fluoxetine; oral

2.0

108.3

1335

7104

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.9

108.1

543

1954

B01AB05

ATC

enoxaparin; parenteral

1.6

108.1

3654

25878

N99

ICPC

Neurological disease other

4.9

107.8

240

498

WX892

NOMESCO Finland

Monitored bed care

2.2

107.5

950

4458

M02AA07

ATC

piroxicam; topical

1.6

107.4

4146

30257

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

107.0

3425

23938

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

106.7

928

4326

C05AA08

ATC

fluocortolone; rectal, topical

1.9

106.7

1553

8736

J01FA09

ATC

clarithromycin; systemic

1.6

106.5

3303

22906

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

106.5

1726

10043

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

106.4

896

4121

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

106.1

443

1436

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.7

106.0

342

941

A02BA04

ATC

nizatidine; systemic

2.3

105.8

899

4150

SPAT1310

SPAT

Counselling related to known health issue

1.6

105.4

3590

25438

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.1

105.3

1117

5628

P03

ICPC

Feeling depressed

2.3

104.8

896

4147

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

104.7

435

1406

SPAT1312

SPAT

General health counselling

1.6

104.5

3523

24896

XKD00

NOMESCO Finland

Uroflowmetry

1.8

104.4

1951

11839

M01AH02

ATC

rofecoxib; oral

1.9

104.3

1507

8451

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

104.2

1533

8649

R04.2

ICD-10 Finland

Haemoptysis

3.0

104.1

479

1642

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

103.8

1242

6535

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

103.7

845

3833

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.2

103.6

417

1322

T05

ICPC

Feeding problem of adult

7.0

103.3

158

229

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

103.3

2549

16684

R19.5

ICD-10 Finland

Other faecal abnormalities

5.9

103.1

185

316

N05BA12

ATC

alprazolam; oral

2.1

102.8

1109

5621

N05CD07

ATC

temazepam; oral

1.9

102.8

1429

7913

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

102.4

946

4517

L04

ICPC

Chest symptom/complaint

2.4

102.3

722

3074

K22.1

ICD-10 Finland

Ulcer of oesophagus

4.2

102.2

274

660

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

102.1

842

3837

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

101.8

544

2023

A02BX02

ATC

sucralfate; oral

2.9

101.7

500

1778

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

101.4

2785

18714

X58

ICD-10 Finland

Exposure to other specified factors

1.9

101.1

1502

8494

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.9

100.8

298

771

JN4AD

NOMESCO Finland

Body CT examination

2.0

100.8

1204

6329

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

5.5

100.5

194

355

Z01.9

ICD-10 Finland

Special examination, unspecified

2.4

100.3

740

3214

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.0

100.2

466

1607

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

100.2

879

4109

R49.03

ICD-10 Finland

Atrophic dysphonia

4.8

100.2

228

482

D11

ICPC

Diarrhoea

2.0

100.0

1150

5962

N06AA10

ATC

nortriptyline; systemic

4.1

99.9

282

706

C01DA14

ATC

isosorbide mononitrate; oral

1.8

99.5

1918

11727

M01AH01

ATC

celecoxib; oral

1.7

99.5

2025

12573

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

99.2

2064

12891

G04BD12

ATC

mirabegron; oral

1.9

99.1

1461

8238

G04CA02

ATC

tamsulosin; oral

1.6

98.6

2832

19221

M01AB05

ATC

diclofenac; systemic, rectal

1.5

98.4

7318

60846

D12

ICPC

Constipation

3.0

98.4

463

1607

A01AB04

ATC

amphotericin B; local oral

2.6

98.2

601

2392

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

98.0

2221

14191

N03AG01

ATC

valproic acid; systemic, rectal

2.4

97.9

679

2867

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

9.4

97.7

116

124

J38.7

ICD-10 Finland

Other diseases of larynx

8.1

97.5

130

161

M01AX17

ATC

nimesulide; oral

1.6

97.4

2705

18201

UDQ02

NOMESCO Finland

Direct laryngoscopy

6.3

97.3

163

260

R06AX27

ATC

desloratadine; oral

1.6

97.2

2846

19394

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

97.2

925

4466

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

96.9

1483

8458

M01AH05

ATC

etoricoxib; oral

1.5

96.6

6661

54456

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

19.3

96.3

SFA20

NOMESCO Finland

Two-surface restoration

1.5

95.8

6188

49901

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

95.2

1643

9718

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.1

94.6

1026

5203

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.0

94.6

204

412

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.5

94.5

636

2648

L02

ICPC

Back symptom/complaint

2.0

94.5

1044

5331

Z50.1

ICD-10 Finland

Other physical therapy

2.4

94.1

677

2906

L12

ICPC

Hand/finger symptom/complaint

1.8

94.0

1751

10587

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

93.9

517

1952

RL130, ,

NOMESCO Finland

12.7

93.9

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

93.8

4341

32695

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

93.4

859

4090

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

93.1

672

2888

H57.1

ICD-10 Finland

Ocular pain

3.1

93.0

403

1335

XF404

NOMESCO Finland

Ambulatory ECG

2.0

92.5

1077

5603

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

92.2

706

3115

R96

ICPC

Asthma

2.0

92.1

1089

5696

A03

ICPC

Fever

1.8

92.0

1636

9756

SBB10

NOMESCO Finland

Dental impressions

2.3

91.9

715

3176

D07AC01

ATC

betamethasone; topical

1.5

91.9

4030

29986

U02

ICPC

Urinary frequency/urgency

1.8

91.8

1553

9124

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.6

91.7

549

2161

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

91.7

715

3179

N05CF02

ATC

zolpidem; oral

1.7

91.5

1835

11321

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

90.8

1551

9136

J45

ICD-10 Finland

Asthma

2.0

90.8

1155

6195

C10AC01

ATC

colestyramine; oral

3.6

90.7

307

872

WX290

NOMESCO Finland

Other blockage of nerve

1.5

90.7

4560

34866

R06.5

ICD-10 Finland

Mouth breathing

2.1

90.6

981

4970

SPAT1097

SPAT

Recording of ECG

1.7

90.3

1717

10433

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

90.2

1509

8832

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

89.6

445

1591

R03AC03

ATC

terbutaline; inhalant

1.8

89.3

1523

8964

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

10.1

89.3

101

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.1

89.2

389

1293

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

89.1

1249

6917

U07

ICPC

Urine symptom/complaint other

2.1

88.9

870

4242

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.6

88.8

142

216

ZXA05

NOMESCO Finland

Left side

1.6

88.7

2920

20383

M54.3

ICD-10 Finland

Sciatica

2.3

88.6

673

2958

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

88.5

651

2821

A04AA01

ATC

ondansetron; systemic, rectal

2.1

88.4

866

4224

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.5

88.3

591

2453

L05

ICPC

Flank/axilla symptom/complaint

2.3

88.2

683

3027

XQ800

NOMESCO Finland

Prick test

2.3

88.0

742

3408

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

4.1

88.0

248

620

D09

ICPC

Nausea

2.9

87.9

430

1524

N03AF01

ATC

carbamazepine; oral, rectal

2.5

87.8

594

2478

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.2

87.6

358

1145

J01CA08

ATC

pivmecillinam; oral

1.5

87.2

4162

31422

G04BD08

ATC

solifenacin; oral

2.1

87.0

831

4013

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

87.0

2182

14266

R33

ICD-10 Finland

Retention of urine

2.0

86.7

990

5111

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

16.8

86.6

R68.2

ICD-10 Finland

Dry mouth, unspecified

6.7

86.6

137

206

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

86.6

2152

14035

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

86.6

721

3295

K59.01

ICD-10 Finland

Constipation outlet obstruction type

6.1

86.4

150

248

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.3

86.4

678

3021

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.1

86.4

241

598

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

86.0

1246

6971

SFA30

NOMESCO Finland

Three-surface restoration

1.5

85.9

4496

34544

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

85.7

608

2592

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

85.6

3204

22977

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.0

85.5

378

1266

SAA04

NOMESCO Finland

Special examination of mouth

2.4

85.4

602

2558

XKC03

NOMESCO Finland

Water cystometry

3.0

85.4

384

1299

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.2

85.4

782

3714

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

85.3

836

4076

R74

ICPC

Upper respiratory infection acute

1.6

85.1

2907

20432

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.7

85.0

482

1846

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

84.9

2816

19660

R30.0

ICD-10 Finland

Dysuria

2.7

84.8

465

1751

J20

ICD-10 Finland

Acute bronchitis

1.9

84.8

1104

5963

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.0

84.5

183

371

XG466

NOMESCO Finland

Sleep oxymetry

2.9

84.4

420

1503

TJD10

NOMESCO Finland

Insertion of other tube into stomach or duodenum

19.8

84.3

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.0

84.2

1007

5281

R1260

NOMESCO Finland

Evaluation of communicative skills

3.7

84.2

269

735

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

11.1

84.0

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.6

83.9

284

807

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

83.8

2610

17953

M54

ICD-10 Finland

Dorsalgia

1.9

83.8

1235

6943

JN4BD

NOMESCO Finland

Extensive body CT

1.9

83.8

1211

6767

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.4

83.6

303

900

Z00.0

ICD-10 Finland

General medical examination

1.6

83.5

2142

14065

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.1

83.4

363

1205

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

83.4

975

5073

ZXA00

NOMESCO Finland

Right side

1.5

83.4

3069

21910

H01

ICPC

Ear pain/earache

1.9

83.1

1117

6096

XJC10

NOMESCO Finland

Oesophageal pH monitoring

9.0

83.0

102

114

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

83.0

722

3358

C01CA24

ATC

epinephrine; parenteral

2.4

82.7

616

2683

ZX120

NOMESCO Finland

Intravenous

1.9

82.5

1049

5618

S29

ICPC

Skin symptom/complaint other

1.6

82.4

2137

14068

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

82.3

676

3070

UDQ22

NOMESCO Finland

Microlaryngoscopy

5.9

82.3

147

250

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.9

82.2

390

1359

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

82.0

2853

20108

P01

ICPC

Feeling anxious/nervous/tense

2.0

81.7

940

4861

ZXA10

NOMESCO Finland

Bilateral

1.6

81.3

2171

14389

M01AC06

ATC

meloxicam; systemic, rectal

1.5

81.3

3900

29377

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

8.2

81.0

107

131

Z51.5

ICD-10 Finland

Palliative care

2.0

80.9

948

4934

R03BA01

ATC

beclometasone; inhalant

1.7

80.6

1565

9545

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.7

80.4

263

730

SPAT1262

SPAT

Handing over of treatment supplies

1.6

80.4

2016

13150

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

79.4

1115

6168

C07AB02

ATC

metoprolol; systemic

1.6

79.3

2366

16088

Z00.8

ICD-10 Finland

Other general examinations

2.1

79.3

847

4264

N06AA12

ATC

doxepin; systemic

2.3

79.1

610

2696

N19

ICPC

Speech disorder

4.0

78.9

224

563

S22.3

ICD-10 Finland

Fracture of rib

2.1

78.8

795

3918

T78.4

ICD-10 Finland

Allergy, unspecified

2.6

78.7

463

1806

N06AX03

ATC

mianserin; oral

2.4

78.7

551

2334

H92.0

ICD-10 Finland

Otalgia

2.3

78.5

592

2591

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

78.5

639

2890

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

78.4

454

1757

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

78.2

994

5319

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.6

77.4

459

1797

C08CA05

ATC

nifedipine; systemic

2.1

77.1

766

3751

R52.0

ICD-10 Finland

Acute pain

3.0

76.8

349

1187

R31

ICD-10 Finland

Unspecified haematuria

1.8

76.8

1183

6734

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

76.8

1126

6312

B01AC04

ATC

clopidogrel; oral

1.6

76.8

1936

12634

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.5

76.8

264

758

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.9

76.7

372

1312

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

76.7

307

970

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

76.5

483

1949

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

76.1

326

1072

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

76.1

472

1889

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

76.1

4567

35783

K92.1

ICD-10 Finland

Melaena

2.3

76.1

614

2767

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

75.8

1508

9249

R4120

NOMESCO Finland

Occupational therapy

2.1

75.7

757

3716

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

75.4

3099

22559

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

75.2

1261

7364

EBA00

NOMESCO Finland

Extraction of tooth

1.5

75.1

3733

28212

KMAK, ,

NOMESCO Finland

1.4

75.0

5296

42691

SPAT1255

SPAT

Intravenous administration of medicine

2.1

74.8

772

3834

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

74.8

1259

7360

RL210, ,

NOMESCO Finland

8.5

74.5

114

UJH02

NOMESCO Finland

Anoscopy

2.6

74.2

458

1829

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

74.0

890

4670

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

73.6

4641

36625

J39.2

ICD-10 Finland

Other diseases of pharynx

5.1

73.6

155

307

A05

ICPC

Feeling ill

2.3

73.5

560

2461

130

Kela drug reimbursment

Malignant tumour

1.9

73.5

1002

5484

WYA10

NOMESCO Finland

Emergency care or similar visit

2.1

73.0

776

3896

N03AX11

ATC

topiramate; oral

3.5

73.0

250

716

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

72.9

2133

14405

U01

ICPC

Dysuria/painful urination

2.0

72.9

797

4043

SPAT1167

SPAT

Insertion of urinary catheter

2.6

72.7

435

1710

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

72.7

1437

8791

M54.1

ICD-10 Finland

Radiculopathy

2.6

72.5

438

1730

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

72.4

343

1194

W19

ICD-10 Finland

Unspecified fall

1.8

72.4

1110

6304

SPAT1058

SPAT

PEF monitoring instruction

1.9

72.2

921

4931

L16

ICPC

Ankle symptom/complaint

1.8

72.2

1172

6775

N05AH03

ATC

olanzapine; systemic

2.2

72.2

607

2782

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

71.9

289

915

K10.3

ICD-10 Finland

Alveolitis of jaws

2.6

71.7

441

1758

H53.2

ICD-10 Finland

Diplopia

2.7

71.6

403

1537

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.2

71.5

293

939

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.9

71.5

216

568

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.7

71.5

391

1470

N07AA02

ATC

pyridostigmine; systemic

6.6

71.4

114

173

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

71.1

645

3047

N06AX26

ATC

vortioxetine; oral

2.1

71.1

670

3213

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

71.1

605

2786

EMB10

NOMESCO Finland

Tonsillectomy

2.5

70.8

480

2003

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

70.7

1412

8657

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.6

70.5

407

1572

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.6

70.3

437

1750

J01DA09

ATC

[U] cefadroxil

1.5

70.1

2704

19383

R52.1

ICD-10 Finland

Chronic intractable pain

6.4

70.0

115

180

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

4.4

69.8

178

413

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

69.6

506

2178

J01MA06

ATC

norfloxacin; oral

1.7

69.5

1382

8461

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

69.5

3630

27606

J46

ICD-10 Finland

Status asthmaticus

3.0

69.4

314

1066

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.8

69.3

349

1256

JDB01

NOMESCO Finland

Laparoscopic gastrostomy

24.6

69.3

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.4

69.0

484

2051

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

68.9

445

1815

JAH00

NOMESCO Finland

Laparotomy

3.3

68.8

266

823

A29

ICPC

General symptom/complaint other

1.7

68.7

1389

8540

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

68.4

775

3980

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.4

68.4

136

256

ZY010

NOMESCO Finland

Hospital outpatient

2.4

68.2

476

2012

P76

ICPC

Depressive disorder

2.3

68.2

564

2566

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

68.1

739

3737

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

68.0

1007

5654

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

67.9

391

1509

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

67.8

308

1048

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

67.7

461

1927

R4110, ,

SPAT

1.9

67.6

955

5284

RD210, ,

NOMESCO Finland

3.7

67.3

216

592

A02BA03

ATC

famotidine; systemic

2.5

67.1

425

1717

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.5

67.0

439

1802

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.3

66.9

509

2235

U05

ICPC

Urination problems other

2.2

66.8

588

2744

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.4

66.8

475

2025

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

66.7

878

4746

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

66.7

781

4057

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

12.3

66.6

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

66.6

671

3300

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

66.6

717

3615

R47.0

ICD-10 Finland

Dysphasia and aphasia

4.4

66.4

167

383

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.0

66.3

808

4255

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

5.5

66.3

129

238

N05BE01

ATC

buspirone; oral

2.9

66.2

311

1078

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

66.1

1122

6565

WZC30

NOMESCO Finland

Teaching

1.6

66.1

1672

10886

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

66.0

464

1968

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

3.1

65.9

282

927

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.2

65.8

135

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

65.7

1256

7601

K92.0

ICD-10 Finland

Haematemesis

3.2

65.7

271

872

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

5.1

65.6

139

277

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

65.3

2459

17502

N28

ICPC

Limited function/disability (N)

3.3

65.1

249

765

R32

ICD-10 Finland

Unspecified urinary incontinence

2.8

65.1

344

1270

G54.0

ICD-10 Finland

Brachial plexus disorders

3.2

64.9

257

807

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

64.9

745

3843

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

64.8

573

2678

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.7

64.8

151

326

L86

ICPC

Back syndrome with radiating pain

2.1

64.7

630

3058

C08DA01

ATC

verapamil; systemic

2.4

64.6

474

2049

KCV04

NOMESCO Finland

Distension of bladder with fluid

5.3

64.5

129

244

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

64.5

469

2019

C15.3

ICD-10 Finland

Malignant neoplasm: Upper third of oesophagus

20.5

64.4

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.7

64.2

364

1393

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.8

64.1

336

1235

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.0

64.1

283

947

UJF92

NOMESCO Finland

Capsular endoscopy

3.5

64.0

224

651

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

63.9

713

3639

SBA00

NOMESCO Finland

Microbiological examinations

2.8

63.9

321

1154

F45.0

ICD-10 Finland

Somatization disorder

9.5

63.8

-1, ,

NOMESCO Finland

1.4

63.8

3258

24591

G04BD07

ATC

tolterodine; oral

2.2

63.8

565

2643

R06.4

ICD-10 Finland

Hyperventilation

4.2

63.6

170

409

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.4

63.4

432

1806

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

63.3

940

5278

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

63.3

1401

8811

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

63.2

1100

6478

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

63.2

276

918

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

63.1

474

2070

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

63.0

1096

6453

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

63.0

2161

15066

M02AA10

ATC

ketoprofen; topical

1.6

62.9

1710

11316

L13

ICPC

Hip symptom/complaint

1.6

62.8

1972

13485

J35.0

ICD-10 Finland

Chronic tonsillitis

2.4

62.8

427

1784

R07.2

ICD-10 Finland

Precordial pain

3.2

62.7

252

798

R49.09

ICD-10 Finland

Unspecified dysphonia

4.2

62.7

169

409

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

62.6

4216

33390

AN1

Coronary angiography

1.7

61.9

1267

7803

R29

ICPC

Respiratory symptom/complaint other

2.0

61.8

698

3578

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

61.8

338

1271

R39.1

ICD-10 Finland

Other difficulties with micturition

2.6

61.1

366

1440

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

60.9

585

2825

D03

ICPC

Heartburn

2.6

60.7

362

1421

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

60.6

589

2856

C08CA01

ATC

amlodipine; oral

1.4

60.6

4357

34836

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.7

60.6

1264

7824

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.0

60.5

273

925

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

60.5

1130

6787

N76.0

ICD-10 Finland

Acute vaginitis

2.3

60.5

462

2032

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.7

60.3

338

1287

N07XX02

ATC

riluzole; oral

11.5

60.2

E87.6

ICD-10 Finland

Hypokalaemia

2.5

60.1

374

1498

F34.1

ICD-10 Finland

Dysthymia

2.6

60.1

348

1346

M60.8

ICD-10 Finland

Other myositis

10.0

60.1

N03AF02

ATC

oxcarbazepine; oral

2.6

60.0

367

1458

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

59.9

1073

6369

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.3

59.7

224

680

N06AX12

ATC

bupropion; oral

2.1

59.7

563

2699

SPAT1234

SPAT

Support of social functional capacity

2.1

59.5

609

3012

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

59.4

664

3390

R19.4

ICD-10 Finland

Change in bowel habit

2.9

59.2

284

996

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.2

59.2

235

739

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.6

58.8

363

1449

N05AA02

ATC

levomepromazine; systemic

2.4

58.7

405

1703

D07AD01

ATC

clobetasol; topical

1.6

58.6

1726

11619

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

58.6

593

2920

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

4.0

58.5

168

426

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

58.4

2617

19220

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.1

58.4

253

838

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

58.2

1137

6912

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.2

58.1

506

2351

K22.7

ICD-10 Finland

Barrett oesophagus

3.7

57.8

181

488

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.0

57.8

672

3478

R09.3

ICD-10 Finland

Abnormal sputum

4.3

57.7

149

349

L29.9

ICD-10 Finland

Pruritus, unspecified

2.8

57.7

292

1054

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

57.6

4005

31777

K11.70

ICD-10 Finland

Hypoptyalism

5.6

57.3

109

197

P29

ICPC

Psychological sympt/compl other

2.1

57.3

564

2748

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

57.2

542

2602

A08

ICPC

Swelling

2.1

57.2

586

2899

XJH10

NOMESCO Finland

Anorectal manometry

15.9

57.2

E000001, ,

ATC

1.5

57.1

2024

14178

Z43.0

ICD-10 Finland

Attention to tracheostomy

13.6

57.0

R03AC13

ATC

formoterol; inhalant

2.1

56.9

549

2654

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.0

56.7

123

250

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

56.7

479

2197

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.1

56.7

566

2772

K29.1

ICD-10 Finland

Other acute gastritis

4.4

56.7

143

329

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

56.5

225

709

A99

ICPC

Disease/condition unspecnature/site

1.8

56.3

982

5780

N06AB05

ATC

paroxetine; oral

2.1

56.3

565

2773

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.1

56.2

569

2801

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

8.0

56.1

SGA01

NOMESCO Finland

Emergency treatment

1.6

56.1

1435

9340

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

5.0

56.1

121

245

N80.9

ICD-10 Finland

Endometriosis, unspecified

5.4

56.0

110

205

SPAT1104

SPAT

Monitoring of emergency patient

1.9

55.9

692

3659

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

55.9

499

2340

E86

ICD-10 Finland

Volume depletion

2.8

55.8

288

1051

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

55.7

248

834

SPAT1211

SPAT

Application of soft bandage

1.8

55.7

938

5464

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

55.7

520

2482

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

2.2

55.7

499

2344

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

55.7

582

2900

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

55.6

3829

30292

U71

ICPC

Cystitis/urinary infection other

2.0

55.5

662

3456

Z2445

NOMESCO Finland

Psychologist

2.5

55.4

367

1514

K22.3

ICD-10 Finland

Perforation of oesophagus

14.9

55.3

R03AK11

ATC

formoterol and fluticasone; inhalant

2.8

55.2

286

1045

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

55.2

2983

22641

G70.0

ICD-10 Finland

Myasthenia gravis

6.5

55.1

140

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.4

55.1

140

324

S80.0

ICD-10 Finland

Contusion of knee

1.9

54.9

705

3775

R1250

NOMESCO Finland

Evaluation of functional capability

2.9

54.8

266

939

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

54.8

2701

20161

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

54.6

546

2676

D13.0

ICD-10 Finland

Benign neoplasm: Oesophagus

9.0

54.5

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

54.4

155

391

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

54.4

452

2059

WX704

NOMESCO Finland

Intubation

1.8

54.4

810

4547

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

54.2

399

1726

R06AX22

ATC

ebastine; oral

1.6

54.2

1635

11049

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

54.2

1004

6009

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.1

54.2

224

722

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.1

54.1

147

358

I20.09

ICD-10 Finland

Unstable angina

2.0

54.0

609

3118

D84

ICPC

Oesophagus disease

8.0

54.0

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.1

53.9

513

2467

M01AB55

ATC

diclofenac, combinations; oral

1.9

53.9

705

3797

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

53.8

286

1060

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

53.7

7195

62884

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.8

53.7

271

977

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

53.7

766

4243

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.2

53.7

141

335

R06AE09

ATC

levocetirizine; oral

1.6

53.6

1358

8815

J38.3

ICD-10 Finland

Other diseases of vocal cords

4.0

53.5

150

374

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

53.5

3746

29668

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.8

53.5

281

1035

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

53.5

684

3657

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

53.5

2078

14813

J38.5

ICD-10 Finland

Laryngeal spasm

10.4

53.4

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.6

53.3

1231

7809

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

53.3

215

683

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.4

53.2

364

1524

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

3.2

53.2

208

648

XA402

NOMESCO Finland

ENMG

2.8

53.1

274

1000

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

52.9

581

2947

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

52.7

633

3312

GBB13

NOMESCO Finland

Revision of tracheostomy

14.2

52.7

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.2

52.6

473

2224

D10

ICPC

Vomiting

2.2

52.6

441

2016

W44

ICD-10 Finland

Foreign body entering into or through eye or natural orifice

3.3

52.6

205

638

R25.2

ICD-10 Finland

Cramp and spasm

2.8

52.5

270

983

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

52.4

2636

19724

H93.1

ICD-10 Finland

Tinnitus

1.9

52.4

716

3912

N30

ICD-10 Finland

Cystitis

1.8

52.3

770

4306

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

52.3

705

3834

N18

ICPC

Paralysis/weakness

2.8

52.3

262

941

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.4

52.2

385

1667

P06

ICPC

Sleep disturbance

1.7

52.0

1087

6718

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

4.3

52.0

136

322

R23

ICPC

Voice symptom/complaint

2.8

52.0

256

911

R09

ICPC

Sinus symptom/complaint

1.9

51.9

715

3915

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

51.8

1300

8414

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

51.6

625

3279

R09.1

ICD-10 Finland

Pleurisy

3.4

51.5

190

571

C10AA05

ATC

atorvastatin; oral

1.3

51.5

4693

38659

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.5

51.5

180

523

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

51.4

2494

18527

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.3

51.4

195

597

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

4.1

51.3

142

351

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

51.2

1001

6076

K08.3

ICD-10 Finland

Retained dental root

1.8

51.2

819

4696

G72.9

ICD-10 Finland

Myopathy, unspecified

4.4

51.1

128

293

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.1

50.9

139

340

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

50.9

608

3176

N81.6

ICD-10 Finland

Rectocele

1.9

50.8

641

3410

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.1

50.8

526

2611

A07EA06

ATC

budesonide; oral, local oral

2.5

50.8

331

1356

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.6

50.7

307

1214

P01BA02

ATC

hydroxychloroquine; oral

1.8

50.7

870

5092

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

50.7

1862

13108

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.9

50.7

244

858

J45.8

ICD-10 Finland

Mixed asthma

2.5

50.6

330

1352

ZXD20

NOMESCO Finland

Day surgery

1.6

50.6

1313

8564

R01AD11

ATC

triamcinolone; nasal

1.8

50.5

854

4978

B01AA03

ATC

warfarin; systemic

1.5

50.4

2176

15811

L15

ICPC

Knee symptom/complaint

1.4

50.3

2427

18002

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

4.8

50.3

112

233

K14.61

ICD-10 Finland

Glossodynia

4.8

50.3

113

237

DQA10

NOMESCO Finland

Biopsy of larynx

5.4

50.3

185

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.3

50.2

128

297

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

50.2

681

3710

SPAT1125

SPAT

Stoma care and guidance

3.1

50.2

212

692

1340

FHL

Hypopharyngoscopy

13.5

50.2

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

4.0

50.1

144

366

F29

ICPC

Eye symptom/complaint other

1.7

50.0

956

5768

N39.3

ICD-10 Finland

Stress incontinence

1.9

50.0

718

3984

R49.0

ICD-10 Finland

Dysphonia

2.9

49.7

233

807

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

49.7

6979

61074

G20

ICD-10 Finland

Parkinson disease

2.2

49.5

415

1897

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

49.5

385

1706

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

49.5

508

2513

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.7

49.5

114

244

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.3

49.4

366

1589

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

49.3

673

3674

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

49.3

1583

10830

R03AC12

ATC

salmeterol; inhalant

2.1

49.2

489

2390

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

49.2

1251

8117

R04.0

ICD-10 Finland

Epistaxis

1.8

49.2

828

4819

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

49.2

209

685

RD160, ,

NOMESCO Finland

9.7

49.1

K86.1

ICD-10 Finland

Other chronic pancreatitis

6.0

49.1

147

C09CA06

ATC

candesartan; oral

1.4

49.1

2447

18247

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.3

49.1

363

1574

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.3

48.9

190

590

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

48.8

251

914

L04AX01

ATC

azathioprine; systemic

2.2

48.8

406

1851

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

48.8

498

2459

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

48.8

803

4643

L14

ICPC

Leg/thigh symptom/complaint

1.8

48.6

824

4804

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

4.6

48.5

114

248

S20.2

ICD-10 Finland

Contusion of thorax

2.0

48.4

526

2657

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

48.4

1603

11038

N41.1

ICD-10 Finland

Chronic prostatitis

2.8

48.3

244

880

A02BDXX, ,

ATC

2.3

48.3

381

1698

M01AX05

ATC

glucosamine; oral

1.4

48.3

2174

15906

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.0

48.3

219

745

P20

ICPC

Memory disturbance

1.5

48.2

1570

10770

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

48.2

1419

9523

JEA00

NOMESCO Finland

Appendectomy

2.2

48.1

426

1991

S01

ICPC

Pain/tenderness of skin

2.1

48.1

470

2283

R10

ICD-10 Finland

Abdominal and pelvic pain

4.1

48.0

130

316

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.4

48.0

177

532

J05AB01

ATC

aciclovir; systemic

1.4

47.9

2150

15718

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

5.7

47.9

154

R06AX13

ATC

loratadine; oral

1.6

47.9

1375

9173

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

47.8

1071

6734

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

47.7

319

1322

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

47.7

507

2540

SPAT1360

SPAT

Extensive global examination

1.8

47.6

770

4427

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

4.0

47.6

136

344

N07CA01

ATC

betahistine; oral

1.8

47.6

786

4548

M54.8

ICD-10 Finland

Other dorsalgia

2.2

47.5

416

1936

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

47.5

282

1105

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

47.3

363

1600

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

47.3

317

1316

T08

ICPC

Weight loss

3.2

47.2

193

618

K04.08

ICD-10 Finland

Other specified pulpit

1.9

47.2

608

3256

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

47.1

291

1162

TGB20

NOMESCO Finland

Tracheostomy tube replacement

17.0

47.1

R25.1

ICD-10 Finland

Tremor, unspecified

2.3

47.0

348

1510

K11.2

ICD-10 Finland

Sialoadenitis

2.4

47.0

342

1473

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

46.9

2202

16227

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

46.9

456

2211

D07AA02

ATC

hydrocortisone; topical

1.6

46.8

1319

8759

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

10.9

46.8

N29

ICPC

Neurological sympt/complt other

2.8

46.7

234

841

J01DC02

ATC

cefuroxime; systemic

2.0

46.6

529

2714

L29

ICPC

Musculoskeletal sympt/complt other

1.7

46.5

875

5253

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.8

46.5

721

4095

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.1

46.4

196

640

SPAT1059

SPAT

Spirometry at the office

2.0

46.4

538

2780

ZXC10

NOMESCO Finland

Use of laser

2.7

46.4

256

967

SPAT1139

SPAT

Nutrition survey

2.3

46.3

366

1633

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

46.3

796

4660

K03.66

ICD-10 Finland

Tooth plaque

1.8

46.2

748

4301

U29

ICPC

Urinary symptom/complaint other

2.4

46.1

323

1367

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.2

46.0

388

1778

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

46.0

317

1332

JG1JB

NOMESCO Finland

Defekography with X-ray

6.3

46.0

123

KH1AD

NOMESCO Finland

CT of urinary organs

2.5

46.0

293

1188

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

45.9

358

1589

JCA60

NOMESCO Finland

Transcervical excision of diverticulum of oesophagus

19.0

45.7

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.1

45.7

197

651

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

45.6

480

2396

K29.6

ICD-10 Finland

Other gastritis

3.9

45.6

134

346

C10AA01

ATC

simvastatin; oral

1.3

45.6

4848

40612

J38.4

ICD-10 Finland

Oedema of larynx

5.7

45.6

151

S22

ICPC

Nail symptom/complaint

1.8

45.6

667

3721

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

3.0

45.5

206

700

K04

ICPC

Palpitations/awareness of heart

2.0

45.4

535

2780

JBC00

NOMESCO Finland

Gastro-oesophageal antireflux operation

7.7

45.4

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.0

45.4

197

654

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

45.2

387

1785

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.7

45.2

250

946

G04CA01

ATC

alfuzosin; oral

1.6

45.1

1312

8771

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.2

45.0

397

1853

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.0

44.9

198

663

M05BA04

ATC

alendronic acid; oral

1.7

44.9

946

5853

G43.3

ICD-10 Finland

Complicated migraine

3.8

44.8

137

364

J01FA01

ATC

erythromycin; systemic

1.6

44.8

1220

8036

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

7.0

44.8

L60.0

ICD-10 Finland

Ingrowing nail

2.0

44.7

466

2318

D07AC13

ATC

mometasone; topical

1.4

44.7

2918

22724

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.5

44.7

153

439

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.3

44.7

346

1531

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

44.6

1704

12064

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.7

44.6

905

5543

S04

ICPC

Lump/swelling localized

1.6

44.6

1015

6403

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

3.5

44.6

156

454

XCK00

NOMESCO Finland

Perimetry

1.8

44.6

706

4034

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

44.5

2102

15489

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.5

44.5

289

1182

K58

ICD-10 Finland

Irritable bowel syndrome

2.8

44.4

230

841

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.2

44.3

401

1891

SPAT1252

SPAT

Overall medication plan or its review

1.8

44.2

748

4358

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.2

44.1

116

276

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

44.1

2944

23000

SPAT1053

SPAT

Memory test

1.5

43.9

1698

12047

SXC05

NOMESCO Finland

Other oral or dental procedure

1.9

43.7

586

3178

N87

ICPC

Parkinsonism

2.9

43.7

213

754

G24.3

ICD-10 Finland

Spasmodic torticollis

4.1

43.6

121

300

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

43.6

303

1279

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

43.5

4574

38179

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

43.5

10036

93406

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

43.3

756

4443

C09AA05

ATC

ramipril; oral

1.4

43.3

2785

21618

SPAT1325

SPAT

Vaccination

1.3

43.2

3682

29825

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.5

43.2

267

1067

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

43.2

672

3819

G24.9

ICD-10 Finland

Dystonia, unspecified

7.0

43.1

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.5

43.0

269

1081

N06AX22

ATC

agomelatine; oral

2.9

43.0

198

680

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

42.9

648

3648

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

42.9

1004

6375

108

Kela drug reimbursment

Myasthenia gravis

6.5

42.9

109

R06.2

ICD-10 Finland

Wheezing

2.1

42.8

428

2096

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

42.8

2256

16936

R01AD01

ATC

beclometasone; nasal

1.5

42.7

1467

10157

K80

ICPC

Cardiac arrhythmia NOS

1.7

42.6

838

5090

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

3.5

42.6

148

429

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

42.5

1134

7429

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.9

42.5

127

332

WX882

NOMESCO Finland

High dependency care

2.4

42.5

292

1226

SFA00

NOMESCO Finland

Small restoration

1.5

42.4

1323

8976

H02AB09

ATC

hydrocortisone; systemic

2.7

42.4

229

856

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.5

42.4

148

430

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

42.3

757

4479

G04BD11

ATC

fesoterodine; oral

2.3

42.2

330

1466

N02AC04

ATC

dextropropoxyphene; oral

2.2

42.2

382

1802

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

9.6

42.1

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

42.0

839

5115

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

5.2

42.0

163

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.9

42.0

561

3040

K90

ICPC

Stroke/cerebrovascular accident

2.2

42.0

347

1578

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

41.9

560

3034

A01AB10

ATC

natamycin; local oral

2.4

41.9

301

1289

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.2

41.9

372

1741

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

41.9

215

783

K04.0

ICD-10 Finland

Pulpitis

1.7

41.8

762

4532

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.4

41.6

149

440

A97

ICPC

No disease

1.4

41.6

1809

13114

N07BB01

ATC

disulfiram; oral

2.2

41.6

360

1668

A06AH03

ATC

naloxegol; oral

3.4

41.6

152

455

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.4

41.5

291

1233

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.1

41.5

112

272

R5110, ,

SPAT

1.7

41.4

717

4203

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

41.4

714

4181

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

41.4

754

4484

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.6

41.3

251

995

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.0

41.3

115

286

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

41.2

1142

7544

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.0

41.2

472

2428

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

7.7

41.2

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

41.0

354

1638

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

41.0

601

3353

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

8.8

41.0

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.1

41.0

414

2036

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.6

40.9

241

941

F01

ICPC

Eye pain

2.5

40.9

268

1101

TAC99

NOMESCO Finland

Other blockade for chronic pain

5.1

40.9

167

K66.0

ICD-10 Finland

Peritoneal adhesions

7.8

40.8

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.2

40.6

357

1665

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.3

40.5

297

1283

N64.4

ICD-10 Finland

Mastodynia

2.4

40.4

272

1132

R01AD05

ATC

budesonide; nasal

1.7

40.4

723

4278

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

40.2

832

5118

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

40.2

2467

18971

A07AA09

ATC

vancomycin; oral

3.2

40.2

157

490

D02AE01

ATC

carbamide; topical

1.8

40.1

635

3625

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

40.1

687

4013

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

40.1

442

2243

B37.08

ICD-10 Finland

Other candidal stomatitis

4.0

40.1

115

292

J01FA15

ATC

telithromycin; oral

1.6

40.1

896

5622

F32

ICD-10 Finland

Depressive episode

2.0

40.0

436

2205

K29

ICPC

Cardiovascular sympt/complt other

1.9

39.8

484

2541

J01DA06

ATC

[U] cefuroxime

1.5

39.8

1359

9390

UDM02

NOMESCO Finland

Sinoscopy

2.6

39.8

226

867

SPAT1050

SPAT

Extensive neurological examination

2.6

39.8

231

896

I20.00

ICD-10 Finland

Unstable angina

2.3

39.8

322

1452

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

39.7

432

2183

S97

ICPC

Chronic ulcer skin

1.8

39.6

653

3774

D25

ICPC

Abdominal distension

3.0

39.6

177

598

EB1VA, ,

NOMESCO Finland

1.6

39.6

1127

7490

K57

ICD-10 Finland

Diverticular disease of intestine

2.8

39.5

199

718

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

39.4

943

6017

SXC03

NOMESCO Finland

Other oral or dental procedure

3.5

39.4

134

383

N06AG02

ATC

moclobemide; oral

2.0

39.4

421

2114

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

39.4

532

2893

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

39.3

685

4021

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

39.3

309

1376

D82

ICPC

Teeth/gum disease

1.3

39.3

3465

28125

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

39.2

367

1754

L50.9

ICD-10 Finland

Urticaria, unspecified

2.2

39.1

343

1597

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

39.1

1645

11840

104

Kela drug reimbursment

Thyroid insufficiency

1.7

39.1

748

4507

F41.00

ICD-10 Finland

Moderate panic disorder

3.7

39.1

125

343

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.9

39.1

497

2650

M77.4

ICD-10 Finland

Metatarsalgia

1.9

39.0

543

2980

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.9

39.0

186

651

J01CF05

ATC

flucloxacillin; systemic

1.8

39.0

590

3324

C03DA01

ATC

spironolactone; oral

1.5

38.9

1216

8245

1410

FHL

Laparoscopy

2.7

38.9

213

802

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.5

38.9

255

1048

D29

ICPC

Digestive symptom/complaint other

2.6

38.8

220

843

N06AX05

ATC

trazodone; oral

2.6

38.8

230

901

P74

ICPC

Anxiety disorder/anxiety state

2.3

38.8

306

1365

H29

ICPC

Ear symptom/complaint other

1.5

38.5

1160

7802

UJD10, ,

SPAT

2.6

38.5

228

893

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.0

38.4

109

275

L19

ICPC

Muscle symptom/complaint NOS

2.3

38.2

285

1241

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

38.2

677

3993

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.5

38.2

252

1039

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

7.7

38.2

K11.72

ICD-10 Finland

Xerostomia

14.0

38.2

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.1

38.1

390

1928

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.6

38.1

918

5867

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

38.1

140

421

NBG10

NOMESCO Finland

Acromioplastia

2.3

38.0

283

1232

M77.1

ICD-10 Finland

Lateral epicondylitis

1.8

37.9

629

3640

R83

ICPC

Respiratory infection other

1.4

37.9

2093

15799

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.0

37.9

164

544

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.0

37.8

110

L04AA06

ATC

mycophenolic acid; systemic

2.9

37.8

178

619

SDA03

NOMESCO Finland

Periodontal treatment

1.3

37.8

3888

32195

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.6

37.7

216

832

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

37.7

535

2954

JF2BD

NOMESCO Finland

Extensive colon CT

4.7

37.7

183

SPAT1283

SPAT

Restricted health certificate

1.5

37.6

1208

8236

N05AX08

ATC

risperidone; systemic

1.6

37.6

836

5237

N06AA06

ATC

trimipramine; systemic

2.5

37.6

237

957

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

37.5

471

2501

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2962

14634

2.35

319.75

2.2

1.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5268

32780

2.06

315.23

4.2

3.1

—

0.60

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5959

38836

2.03

312.77

3.4

2.7

132.07

139.26

ug/l

0.67

5416

35560

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3481

18643

2.21

307.81

2.0

1.6

1.19

1.33

mg/l

1.12

2628

14422

(3022096) Basophils/100 leukocytes in Blood

6592

41950

2.22

307.65

6.9

5.8

0.65

0.67

1.88

6133

38835

(3013707) Erythrocyte sedimentation rate by Westergren method

9617

70750

2.61

307.65

5.4

3.8

13.11

12.94

mm/h

0.49

8947

64812

(3002030) Lymphocytes/100 leukocytes in Blood

6886

44747

2.22

307.65

7.1

5.9

26.80

27.34

3.58

6444

41692

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9952

73116

2.85

307.65

9.3

6.6

78.56

77.76

u/l

0.87

9422

68153

(3031040) Bacteria [#/volume] in Urine by Automated count

8736

61848

2.40

307.65

6.6

4.0

1014.57

1739.13

e6/l

0.74

122

948

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5201

28536

2.42

307.65

2.6

2.0

189.06

231.28

u/l

1.26

4929

26502

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7671

45363

2.82

307.65

6.7

5.5

10.73

11.40

umol/l

5.85

7274

42679

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4208

23612

2.19

307.65

2.5

2.2

2.91

3.01

mg/l

1.88

3595

19925

(3006315) Basophils [#/volume] in Blood

7243

46157

2.37

307.65

6.6

5.5

0.04

e9/l

1.27

6350

39261

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3041

14557

2.44

307.65

4.0

3.0

0.81

0.82

mmol/l

5.85

2829

13502

(3013650) Neutrophils [#/volume] in Blood by Automated count

7980

53163

2.41

307.65

9.9

8.5

4.18

4.12

e9/l

1.33

7091

45730

(3037467) Urinalysis macro (dipstick) panel - Urine

9007

65139

2.41

307.65

6.0

3.9

—

(3019198) Lymphocytes [#/volume] in Blood

7354

47406

2.36

307.65

6.7

5.6

1.89

1.91

e9/l

0.49

6576

41265

(40768797) Stomach Pathology biopsy report

3945

10119

5.26

307.65

1.4

1.2

—

(3013115) Eosinophils [#/volume] in Blood

7431

47722

2.40

307.65

6.9

5.8

0.19

0.20

e9/l

0.80

6579

41178

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6205

40666

2.06

307.65

2.3

1.9

94.94

95.30

pmol/l

0.23

3273

20694

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6867

43931

2.27

307.65

7.4

5.5

1.21

mmol/l

1.71

6263

39653

(3019069) Monocytes/100 leukocytes in Blood

6790

43582

2.24

307.65

7.2

6.1

8.54

8.69

3.32

6347

40509

(3001604) Monocytes [#/volume] in Blood

7225

46052

2.37

307.65

6.6

5.5

0.59

0.60

e9/l

1.94

6333

39178

(3018010) Neutrophils/100 leukocytes in Blood

6803

44006

2.21

307.65

6.8

5.6

58.14

57.70

2.17

6355

40973

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5259

23830

3.10

307.65

3.0

2.1

61.24

60.99

u/l

0.02

4832

21541

(3024561) Albumin [Mass/volume] in Serum or Plasma

6714

40725

2.42

307.65

5.5

4.2

34.87

35.39

g/l

10.78

6237

37452

(3006504) Eosinophils/100 leukocytes in Blood

6774

43308

2.25

307.65

6.9

5.8

2.84

2.87

0.40

6320

40178

(3022217) INR in Platelet poor plasma by Coagulation assay

7076

44101

2.41

307.65

17.6

16.1

1.28

1.33

inr

2.38

2057

11999

(3013826) Glucose [Moles/volume] in Serum or Plasma

8235

55030

2.48

307.65

6.3

4.2

6.62

6.80

mmol/l

13.11

7858

51168

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7553

48319

2.45

307.65

8.1

6.1

1.21

1.22

mmol/l

0.93

6463

40627

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5864

34858

2.30

307.65

4.9

3.3

98.35

82.96

ng/l

0.12

4237

24872

(40760892) CBC W Ordered Manual Differential panel - Blood

6870

43182

2.33

307.65

7.2

6.1

—

(3023368) Bacteria identified in Blood by Culture

4364

25091

2.14

307.65

5.4

4.0

—

(3026008) Bacteria identified in Urine by Culture

4735

28593

2.06

305.07

4.1

2.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1818

7363

2.72

298.13

2.3

2.2

375.00

382.48

nmol/l

0.72

1640

6736

(3048689) Calprotectin [Mass/mass] in Stool

1993

8483

2.61

295.64

2.1

2.2

145.79

135.58

ug/g

0.32

1587

6600

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9450

73639

2.20

293.57

5.2

3.8

14.96

14.87

pmol/l

2.70

8602

66164

(3015377) Calcium [Moles/volume] in Serum or Plasma

5173

32593

2.01

292.95

3.4

3.3

2.34

2.36

mmol/l

10.22

4444

28275

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1521

5796

2.85

279.28

1.9

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3234

17547

2.14

271.32

1.4

1.2

1.31

1.81

u/ml

1.47

802

4612

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4639

28722

1.98

270.65

3.4

2.9

1398.57

1562.53

ng/l

1.76

3972

24734

(3019309) Folate [Moles/volume] in Red Blood Cells

3382

18812

2.10

264.77

1.9

1.7

1150.35

1162.08

nmol/l

0.29

2509

13920

(3007164) IgA [Mass/volume] in Serum or Plasma

2897

15218

2.18

262.94

1.6

1.4

2.42

2.49

g/l

0.77

1706

8842

(3002582) Erythrocytes [#/volume] in Urine

4490

27717

1.97

262.26

4.2

3.0

44.68

109.79

e6/l

6.12

3579

20732

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5835

39340

1.91

261.52

2.6

2.1

78.92

78.56

nmol/l

0.42

5182

34802

(3018095) Leukocytes [#/volume] in Urine

5060

32689

1.93

256.86

4.9

3.4

82.78

115.93

e6/l

2.72

3799

22376

(3044640) Blood type and Crossmatch panel - Blood

4631

29140

1.94

253.60

3.0

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7896

59093

1.93

253.48

4.0

2.7

51.77

45.92

u/l

5.62

7291

54230

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2413

11938

2.27

252.84

6.1

5.3

1.02

1.04

mmol/l

2.20

2238

11014

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6279

43819

1.88

248.37

3.1

2.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

721

1873

4.03

244.20

1.6

1.3

273.62

277.78

ug/g

0.20

428

1131

(3021960) Folate [Moles/volume] in Serum or Plasma

3817

22788

1.98

241.49

1.7

1.5

20.87

20.36

nmol/l

1.18

3259

19234

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4444

27975

1.92

239.83

3.6

2.9

31.77

32.87

u/l

0.71

4197

26377

(3000850) Epithelial cells [#/volume] in Urine

3301

18789

2.03

238.76

3.1

2.5

5.40

5.01

e6/l

0.89

2986

16682

(3030467) Casts [#/volume] in Urine by Automated count

4132

25449

1.94

237.72

4.0

2.9

0.44

0.45

e6/l

0.15

3287

18946

(3026782) Osmolality of Urine

3192

17988

2.04

237.11

3.5

2.7

514.58

547.31

mosm/kgh2o

1.65

2734

15280

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1755

7792

2.46

234.27

2.3

1.9

0.21

g/l

0.82

1624

7201

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11249

97127

2.74

233.73

24.6

12.5

23.33

24.82

mg/l

5.44

9734

75055

(3037522) Nuclear Ab [Titer] in Serum

2257

11239

2.23

230.71

1.4

1.3

678.35

543.52

titre

2.10

509

2458

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3118

17642

2.03

227.64

5.0

3.4

304.70

596.55

ng/l

2.14

2433

14533

(3018418) pH of Serum or Plasma

4489

28766

1.88

226.12

4.8

3.8

7.40

0.01

850

5352

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1849

8567

2.36

223.65

2.6

2.3

7.69

8.21

umol/l

0.52

1560

7369

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1505

6360

2.56

222.61

3.0

1.9

33.05

39.10

u/l

2.75

1291

5294

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3628

22035

1.91

213.04

2.8

2.2

—

(36304419) Bacteria [Presence] in Urine

3954

24706

1.88

212.64

4.0

2.9

—

(3035350) Ketones [Presence] in Urine by Test strip

6332

45770

1.79

209.47

4.9

3.4

0.00

estimate

3.46

1325

8790

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10582

90062

2.21

207.18

6.5

4.5

1.87

2.13

mu/l

4.91

9735

81498

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2021

10075

2.20

203.75

2.1

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

6371

46379

1.77

203.37

4.9

3.4

0.00

estimate

0.99

1203

7999

(3022948) Iron [Moles/volume] in Serum or Plasma

2647

14697

2.02

200.27

2.7

2.4

12.19

12.77

umol/l

3.99

2453

13633

(3021601) Nitrite [Presence] in Urine by Test strip

6299

45850

1.76

199.79

6.5

4.5

0.00

estimate

1.60

1226

8202

(3013512) EKG study

4313

28189

1.81

197.37

4.9

3.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1986

10131

2.14

187.56

2.1

1.7

—

(3000494) Fungus identified in Specimen by Culture

2036

10498

2.12

186.95

1.6

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

3674

23182

1.83

186.59

5.0

3.4

88.65

88.75

0.08

3599

22594

(3015736) pH of Urine

5222

36624

1.74

183.70

4.4

3.2

5.90

5.85

0.43

264

2291

(40768804) Tissue Pathology biopsy report

5460

38795

1.73

183.07

2.4

2.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

291

443

6.70

181.78

1.1

5.70

8.30

nmol/l

0.32

105

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2436

13551

1.99

181.19

2.6

2.4

2.30

2.31

g/l

0.27

2236

12487

(3007853) Bacteria identified in Skin by Aerobe culture

2059

10796

2.09

180.29

2.0

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2312

12729

2.00

176.62

2.7

2.5

21.19

22.16

2.71

1956

10766

(3042936) Bacteria identified in Isolate by Culture

2275

12506

2.00

174.32

2.3

1.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2530

14469

1.94

172.62

2.1

1.9

30.03

29.86

0.63

2429

14040

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2971

18034

1.85

168.04

3.1

3.0

2.46

mmol/l

0.09

2557

15696

(3019550) Sodium [Moles/volume] in Serum or Plasma

11383

101860

2.47

165.09

26.9

15.1

139.48

139.74

mmol/l

21.54

11182

98857

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2662

15684

1.89

164.99

3.4

2.6

1.11

1.34

e6/l

0.62

1617

8806

(3012544) pH of Venous blood

1681

8490

2.13

161.05

4.3

3.6

7.37

7.38

0.42

(3023103) Potassium [Moles/volume] in Serum or Plasma

11389

102171

2.44

160.06

27.1

15.2

3.97

3.98

mmol/l

3.70

11165

98954

(3002032) Base excess in Venous blood by calculation

1629

8160

2.15

159.30

4.3

3.7

2.27

1.85

mmol/l

4.69

1431

6869

(3005322) IgE [Units/volume] in Serum or Plasma

1128

4847

2.46

158.56

1.4

1.3

192.03

245.99

u/ml

1.45

1037

4448

(3005719) IgG [Mass/volume] in Serum or Plasma

1316

6061

2.31

158.13

2.7

10.19

10.63

g/l

2.78

1208

5513

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2533

14877

1.88

157.64

1.4

1.2

33.69

37.10

iu/ml

0.46

739

4796

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2307

13147

1.93

157.44

1.7

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1270

5778

2.34

156.96

5.2

3.4

5.33

5.15

kpa

9.01

1199

5423

(3009343) pH of Capillary blood

1253

5707

2.33

154.35

5.2

3.4

7.41

7.42

0.46

146

731

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1620

8203

2.12

153.68

4.3

3.6

5.95

5.83

kpa

4.67

1566

7958

(3019225) pH of Specimen

1801

9517

2.04

152.27

4.5

4.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1968

10779

1.98

150.25

7.7

6.7

5.17

5.10

kpa

2.44

1861

10241

(3027801) Oxygen [Partial pressure] in Arterial blood

1965

10772

1.98

149.58

7.7

6.7

11.94

12.31

kpa

2.52

1860

10234

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2454

14513

1.86

148.36

3.7

2.8

2.34

2.40

e6/l

0.12

1406

7687

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1576

8028

2.10

146.74

2.5

2.2

6.49

8.19

ug/l

2.11

1302

6932

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2375

14000

1.86

144.65

1.3

1.2

12.09

15.32

u/ml

0.52

828

5206

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1203

5531

2.30

144.56

5.1

3.4

2.28

1.83

mmol/l

3.46

934

4091

(3014111) Lactate [Moles/volume] in Serum or Plasma

1521

7705

2.11

143.51

7.5

6.7

1.33

1.37

mmol/l

0.64

1474

7480

(3003396) Base excess in Arterial blood by calculation

1947

10791

1.95

143.00

7.7

6.7

1.56

1.04

mmol/l

6.27

1556

8545

(40758558) Short blood count panel - Blood

3497

23168

1.71

142.45

7.5

6.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1142

5254

2.29

136.70

1.2

—

(3022145) Colonoscopy Study observation

1687

9126

1.98

132.13

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1101

5098

2.27

129.52

1.7

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6877

54672

1.58

129.41

3.2

2.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

885

3732

2.48

128.73

2.1

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1137

5356

2.24

128.27

3.1

3.3

4.39

4.43

pmol/l

0.69

993

4748

(3016502) Oxygen saturation in Arterial blood

1738

9624

1.94

126.74

8.1

7.0

95.43

95.47

0.09

1681

9237

(3020630) Protein [Mass/volume] in Serum or Plasma

1511

7983

2.02

126.18

2.4

2.5

65.65

66.46

g/l

3.51

1358

7160

(3027945) Reticulocytes/100 erythrocytes in Blood

1919

11020

1.88

125.10

2.4

1.71

1.76

1.19

1654

9661

(3015171) Extractable nuclear Ab [Units/volume] in Serum

789

3200

2.57

124.54

1.3

1.2

0.56

1.14

u/ml

1.21

278

(3024354) Oxygen [Partial pressure] in Venous blood

1323

6714

2.09

123.18

3.8

3.0

4.55

4.52

kpa

0.18

1267

6482

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1131

5406

2.20

122.88

1.9

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1893

10970

1.86

119.43

3.6

4.1

237.70

248.41

u/l

2.12

1771

10293

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

776

3185

2.53

119.37

2.4

2.3

269.81

731.79

ug/l

4.38

723

2997

(3022313) Gas panel - Capillary blood

934

4188

2.33

118.15

5.5

3.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1015

4732

2.25

117.03

2.0

1.9

1.33

1.42

g/l

0.42

932

4252

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

809

3421

2.46

116.69

2.0

1.7

—

(4200892) Spirometry reversibility

1310

6762

2.05

116.14

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3114

20992

1.65

114.07

1.8

1.7

29040255.93

26921028.96

pmol/l

0.07

2562

17065

(36660697) Celiac disease serology panel - Serum

1230

6283

2.06

112.01

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4703

35068

1.55

111.74

5.3

3.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1158

5797

2.10

111.28

2.5

2.3

20.67

24.01

au/ml

0.46

436

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1343

7101

2.00

111.08

3.7

3.6

83.31

90.68

ng/l

2.00

1145

6100

(3023419) Bacteria identified in Sputum by Culture

426

1320

3.31

109.94

2.6

2.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3572

25114

1.59

109.23

2.9

2.6

4681.20

5324.21

umol/l

0.40

3014

21750

(3020779) Urea [Moles/volume] in Serum or Plasma

1486

8197

1.92

108.46

7.7

6.5

9.24

10.53

mmol/l

9.91

1418

7726

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1069

5250

2.13

107.88

1.3

59.63

58.16

au/ml

0.04

309

(3011397) Hemoglobin [Presence] in Urine by Test strip

3185

21866

1.61

107.23

4.6

3.4

—

(3025941) Bacteria identified in Stool by Culture

920

4268

2.25

107.05

1.3

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10336

92396

1.72

105.02

20.9

12.4

79.50

78.11

ml/min/173m2

8.40

9000

74795

(3004588) Protein electrophoresis panel - Serum or Plasma

1263

6693

1.99

103.42

2.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11367

104748

2.05

102.77

26.5

15.2

78.53

78.63

umol/l

0.09

11361

104705

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

467

1594

3.01

102.29

1.4

1.3

—

(3021589) Normoblasts [#/volume] in Blood

5443

42442

1.50

101.89

12.8

8.9

0.00

e9/l

1.93

4455

34421

(3000991) Gas panel - Venous blood

1377

7569

1.92

101.16

9.2

7.9

—

(3000492) Spirometry study

1490

8431

1.87

100.06

1.6

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1003

4975

2.11

98.30

9.1

8.7

24.73

24.28

mmol/l

3.88

958

4796

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

969

4756

2.13

97.60

2.5

2.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

577

2270

2.62

96.55

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10613

96122

1.73

95.81

5.5

4.6

5.97

5.96

mmol/l

0.03

9615

86795

(3023520) Reticulocytes [#/volume] in Blood

1439

8176

1.86

95.09

2.5

67.06

68.84

e9/l

1.17

1092

6146

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1518

8794

1.83

94.17

8.8

7.5

120.30

121.03

g/l

0.71

1482

8534

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

533

2041

2.68

94.12

1.3

545.82

538.80

mg/l

0.08

506

1931

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11351

105023

1.98

94.10

14.3

9.4

25.04

25.36

u/l

0.86

11002

100488

(3019060) Gas panel - Arterial blood

1163

6184

1.97

93.89

5.0

4.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10166

91170

1.65

93.67

6.9

5.8

40.08

39.96

mmol/mol

0.54

9301

83497

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

661

2828

2.41

92.51

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1050

5419

2.02

92.20

8.5

6.8

25.30

24.75

mmol/l

5.23

1041

5369

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1567

9223

1.80

92.10

3.2

4.0

14.99

20.62

ug/l

0.72

1271

7544

(3003327) Ova and parasites identified in Stool by Light microscopy

576

2320

2.56

91.78

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

788

3665

2.23

90.74

5.9

3.7

25.40

24.88

mmol/l

4.48

723

3331

(40761511) CBC panel - Blood by Automated count

11092

102175

1.83

88.74

22.1

12.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

715

3227

2.29

88.46

2.9

2.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

601

2547

2.43

85.81

1.7

1.5

1.17

g/l

0.16

575

2420

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

563

2319

2.50

85.50

1.4

1.2

35.38

47.10

u/ml

0.52

148

(3023183) Ammonium ion [Moles/volume] in Plasma

425

1520

2.86

85.47

2.5

1.9

29.94

31.81

umol/l

1.10

377

1343

(3026389) Candida sp identified in Specimen by Organism specific culture

358

1171

3.12

84.36

1.6

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

582

2457

2.44

83.78

1.7

1.5

0.23

g/l

0.49

549

2331

(3029937) Albumin [Presence] in Urine by Test strip

3389

24756

1.51

82.44

5.4

3.7

0.00

estimate

0.10

1180

7822

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

468

1794

2.67

82.38

1.3

3.78

3.79

mmol/l

0.08

433

1681

(3044290) Cell count panel - Cerebral spinal fluid

444

1660

2.74

82.08

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

856

4275

2.08

81.93

4.1

3.0

25.75

25.19

mmol/l

4.46

826

4145

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1037

5545

1.95

81.91

1.2

106.11

148.18

iu/ml

2.93

366

2087

(3019150) Specific gravity of Urine by Refractometry

2835

20001

1.54

80.93

5.4

3.8

1.02

kg/l

0.83

464

3054

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

836

4166

2.08

80.45

4.3

4.2

24.50

24.06

mmol/l

3.32

810

4073

(3004119) Hemoglobin [Mass/volume] in Venous blood

997

5294

1.96

80.32

4.0

3.1

126.29

128.30

g/l

2.04

967

5164

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1430

8518

1.77

79.96

3.5

2.7

186.09

222.30

ng/l

2.65

1323

7776

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

501

2044

2.51

77.58

1.6

1.5

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

111

8.80

77.54

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3280

24055

1.49

77.30

4.6

3.1

—

(3044889) 12 lead EKG panel

8016

69538

1.43

74.74

4.9

3.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

741

3626

2.11

74.71

2.2

1.9

1.56

2.37

ug/l

1.62

642

3157

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

578

2565

2.31

74.21

1.8

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

786

3942

2.06

74.20

1.4

1.6

12.08

17.24

u/ml

0.40

126

(3024980) IgG subclass 4 [Mass/volume] in Serum

329

1110

3.02

73.48

1.5

0.76

0.84

g/l

0.50

235

843

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

451

1802

2.56

72.94

1.4

36.92

35.28

e6/l

0.03

340

1397

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

451

1803

2.56

72.85

1.5

5691.98

1097.75

e6/l

0.46

360

1466

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1498

9282

1.70

72.25

1.8

1.6

1.57

1.46

5.66

1265

8044

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

740

3700

2.06

70.36

1.1

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

291

939

3.15

70.17

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

502

2151

2.39

69.80

1.4

1.2

5.84

5.00

u/ml

0.23

332

(3015235) Bicarbonate [Moles/volume] in Capillary blood

517

2245

2.36

69.75

4.1

2.9

25.52

24.87

mmol/l

2.78

509

2196

(3025468) Yersinia sp identified in Specimen by Organism specific culture

284

910

3.17

69.30

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

283

911

3.16

68.52

1.4

—

(3003181) Sodium [Moles/volume] in Urine

388

1487

2.66

68.28

1.5

1.3

59.99

65.85

mmol/l

1.83

305

1187

(3005988) Vibrio sp identified in Specimen by Organism specific culture

282

912

3.14

67.75

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

874

4695

1.93

67.68

3.3

2.6

0.25

0.29

e6/l

0.55

854

4586

(46235355) HIV 1 and 2 tests - Meaningful Use set

1908

12753

1.59

67.68

1.8

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

478

2037

2.40

67.26

5.1

3.0

8.15

8.04

kpa

0.73

470

1988

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

281

911

3.13

67.23

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

721

3631

2.05

67.16

1.8

1.9

39.37

39.03

u/l

0.16

628

3139

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

764

3940

2.00

66.60

4.9

3.6

48.90

47.47

0.87

754

3888

(3014007) Fractional oxyhemoglobin in Arterial blood

1024

5816

1.83

66.60

10.0

8.6

93.69

93.86

0.37

1017

5792

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

434

1784

2.48

66.08

1.3

1.2

4.69

5.16

u/ml

0.05

131

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

418

1689

2.53

66.01

1.3

1.2

35.03

51.78

u/ml

1.56

183

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

660

3247

2.09

65.46

1.1

7.58

12.17

u/ml

0.21

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

279

916

3.09

65.34

4.4

3.7

—

(1616796) Gas panel - Central venous blood

459

1947

2.41

65.25

4.9

3.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

280

923

3.08

65.12

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

726

3716

2.01

64.61

2.2

2.3

7.32

7.47

g/l

1.52

648

3300

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

487

2130

2.34

64.59

1.4

1.2

7.08

7.17

u/ml

0.01

207

(3017732) Neutrophils [#/volume] in Blood

1057

6118

1.80

64.50

2.8

3.0

5.23

5.00

e9/l

0.19

775

4769

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

464

1990

2.38

64.35

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

690

3479

2.04

64.01

2.2

2.4

2.86

3.00

g/l

2.64

613

3065

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

723

3713

2.01

63.72

2.2

2.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

693

3523

2.02

62.82

1.1

127.67

206.44

titre

—

104

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

429

1797

2.44

62.69

1.3

1.2

8.23

10.42

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

719

3710

2.00

62.50

2.2

2.3

3.67

3.73

g/l

0.38

643

3295

(3017181) Myelocytes/100 leukocytes in Blood

1256

7708

1.70

62.24

4.3

3.9

0.87

0.96

0.55

482

2583

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1013

5863

1.79

61.73

10.0

8.4

1.36

0.03

1003

5821

(3002179) Metamyelocytes/100 leukocytes in Blood

1161

6995

1.73

61.50

4.1

3.8

0.80

0.72

0.38

440

2211

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1010

5851

1.79

61.34

10.1

8.5

0.67

0.05

1000

5814

(3017143) Hepatitis C virus Ab [Presence] in Serum

1364

8618

1.65

60.39

1.7

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

891

5000

1.84

60.05

10.7

9.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

723

3799

1.96

59.60

5.5

4.7

1.60

1.63

0.36

682

3539

(3021440) Promyelocytes/100 leukocytes in Blood

1199

7355

1.70

59.37

4.4

4.0

0.08

0.11

1.33

423

2246

(3009542) Hematocrit [Volume Fraction] of Blood

11563

109699

1.83

59.05

34.7

19.1

39.20

40.22

16.65

10836

101621

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

569

2752

2.12

58.95

3.0

3.2

616.06

1596.12

u/ml

1.06

492

2341

(3007461) Platelets [#/volume] in Blood

11566

109782

1.82

58.31

34.6

19.0

250.46

248.41

e9/l

2.58

11350

106181

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

226

704

3.25

57.83

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

377

1547

2.48

57.60

2.5

2.1

3585.36

3783.86

u/l

0.05

121

627

(3035941) MCH [Entitic mass]

11566

109836

1.81

57.44

34.3

18.9

30.31

30.35

1.21

11432

107828

(3024731) MCV [Entitic volume]

11566

109846

1.81

57.28

34.4

18.9

91.35

91.25

1.58

11433

107829

(3010813) Leukocytes [#/volume] in Blood

11566

109855

1.81

57.14

34.5

19.0

6.89

6.70

e9/l

11.01

11321

105874

(40761535) Cells panel - Urine sediment

1231

7678

1.67

57.13

4.0

3.3

—

(3026361) Erythrocytes [#/volume] in Blood

11566

109857

1.81

57.11

34.5

19.0

4.39

4.47

e12/l

59.92

11321

105896

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

805

4445

1.87

57.04

1.7

1.6

1.51

1.56

g/l

0.88

684

3778

(3000963) Hemoglobin [Mass/volume] in Blood

11568

109886

1.81

57.04

34.8

19.1

132.00

135.00

g/l

89.37

11445

107878

(3008152) Bicarbonate [Moles/volume] in Arterial blood

998

5891

1.76

56.67

7.8

6.5

25.07

24.61

mmol/l

3.31

955

5583

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

444

1978

2.29

56.38

1.5

1.3

—

(3045414) Leukocytes [Presence] in Urine

710

3791

1.93

55.75

2.1

1.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

442

1978

2.28

55.53

1.5

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

489

2282

2.19

55.48

1.2

1.1

—

(3021901) Oxygen saturation in Capillary blood

391

1665

2.39

55.08

3.6

2.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

607

3085

2.02

54.97

1.6

224.23

306.44

titre

0.34

153

(42529406) Shigella sp [Presence] in Stool by Culture

488

2290

2.18

54.60

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

623

3215

1.99

54.02

2.8

0.34

0.36

u/ml

0.79

349

1847

(3025159) Blasts/100 leukocytes in Blood

1130

6989

1.68

54.02

4.4

4.0

0.11

0.54

2.70

364

1910

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

665

3510

1.95

54.01

2.2

2.3

9.97

10.36

g/l

1.51

580

3076

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

363

1513

2.44

53.62

1.5

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

336

1354

2.52

53.36

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

336

1354

2.52

53.36

1.5

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

291

1094

2.70

53.21

1.3

0.64

2.66

nmol/l

0.82

275

1055

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

480

2264

2.17

53.00

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

361

1513

2.43

52.68

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

290

1094

2.69

52.67

1.3

0.21

0.23

nmol/l

0.21

(4062490) Immunoglobulin typing, IgG

223

734

3.08

52.05

1.4

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

690

3737

1.90

51.83

5.7

4.7

0.88

0.89

0.10

655

3480

(3008295) Osmolality of Serum or Plasma

239

823

2.94

51.53

1.4

281.29

279.36

mosm/kgh2o

0.52

180

616

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

171

482

3.58

51.22

1.7

1.4

5.69

6.53

u/l

0.67

148

404

(3028192) IgG subclass 2 [Mass/volume] in Serum

223

741

3.05

51.21

1.4

1.3

2.94

3.00

g/l

0.16

153

529

(3027135) IgG subclass 1 [Mass/volume] in Serum

222

740

3.04

50.70

1.4

1.3

6.43

7.03

g/l

1.69

151

527

(3024139) IgG subclass 3 [Mass/volume] in Serum

222

741

3.03

50.59

1.4

1.3

0.36

0.45

g/l

3.01

153

528

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

229

780

2.97

50.35

1.6

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

305

1208

2.56

50.23

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

548

2774

2.02

50.14

6.2

5.6

1.28

1.33

mmol/l

0.54

489

2434

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

188

572

3.32

50.02

1.2

1.1

61.26

43.43

mg/l

0.86

164

472

(3017315) Amylase [Enzymatic activity/volume] in Urine

116

252

4.64

49.47

1.2

1.1

154.80

411.91

u/l

1.30

105

229

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

508

2519

2.06

49.19

1.4

13.79

15.14

iu/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

149

394

3.82

49.02

1.3

1.2

—

(3010421) pH of Blood

480

2335

2.10

48.92

5.9

3.8

7.42

0.17

440

2121

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

148

391

3.82

48.75

1.3

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

431

2016

2.18

48.60

6.2

3.9

8.55

8.47

kpa

0.48

421

1965

(3052851) Hemolysis interference index of Serum or Plasma

529

2674

2.02

48.58

3.4

3.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

317

1300

2.48

48.51

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

606

3215

1.93

48.41

2.5

0.77

1.04

g/l

1.01

513

2719

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

941

5703

1.70

48.35

2.0

1.8

—

(3012501) Base excess in Blood by calculation

428

2001

2.18

48.32

6.2

3.8

2.72

2.52

mmol/l

0.76

329

1348

(3013290) Carbon dioxide [Partial pressure] in Blood

428

2002

2.18

48.26

6.2

3.9

5.11

4.99

kpa

2.78

418

1952

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

180

547

3.32

48.00

1.1

361.46

276.15

mg/l

1.17

161

477

(3016018) Differential panel - Cerebral spinal fluid

240

862

2.82

47.92

1.4

1.5

—

(4035726) Immunohistochemistry procedure

1307

8648

1.57

47.17

1.5

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

173

521

3.35

46.81

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

199

653

3.08

46.73

1.5

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1233

8090

1.58

46.09

5.0

3.5

1.22

1.23

mmol/l

3.59

1087

6950

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

425

2025

2.14

45.72

1.1

4.56

8.97

u/ml

0.94

239

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

260

999

2.64

45.57

1.3

—

(3022621) pH of Urine by Test strip

967

6007

1.66

45.16

3.8

2.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

282

1139

2.51

44.60

6.5

5.9

11.85

11.78

mg/l

0.09

253

1023

(3035637) Corticotropin [Mass/volume] in Plasma

263

1028

2.59

44.53

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

655

3660

1.83

44.49

2.5

2.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

341

1503

2.30

44.41

2.8

3.1

453.61

731.59

u/ml

0.56

302

1361

(3002256) Pathology report gross observation

1738

12370

1.47

44.26

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1770

12657

1.46

43.97

8.7

6.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

142

394

3.63

43.60

1.1

1.08

1.07

u/l

0.05

178

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1718

12249

1.47

43.28

5.0

4.6

33.00

32.79

0.32

1235

8083

(3042631) Mycobacterium sp identified in Specimen

307

1308

2.38

43.23

2.9

2.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

269

1079

2.53

43.18

1.3

1.2

62.43

54.84

u/ml

0.16

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

227

841

2.73

42.77

2.8

3.2

4.95

13.52

nmol/l

0.71

217

818

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10023

93331

1.39

42.76

4.6

3.9

1.30

1.27

mmol/l

3.82

9054

84441

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1433

9887

1.51

42.44

4.6

3.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1008

6425

1.62

42.40

2.1

1.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

277

1139

2.46

42.18

1.5

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

421

2063

2.08

42.07

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

422

2071

2.07

42.00

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

549

2964

1.89

41.54

2.1

2.2

37.68

37.50

g/l

0.29

470

2542

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

528

2815

1.91

41.52

2.2

2.3

0.01

0.03

g/l

0.84

478

2545

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

374

1763

2.16

41.36

1.2

60.00

193.78

titre

—

(3036489) Thrombin time

580

3195

1.86

41.21

1.9

21.84

21.70

0.15

513

2804

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

434

2170

2.04

41.06

1.6

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1513

10649

1.48

40.50

1.7

1.5

—

(3023410) Appearance of Cerebral spinal fluid

216

804

2.72

40.35

1.5

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

492

2587

1.94

40.32

1.8

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

243

961

2.56

40.20

1.4

1.3

—

nmol/l

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

471

2446

1.96

40.03

2.5

2.3

3.67

3.65

g/l

0.09

451

2317

(3034770) Mitochondria Ab [Titer] in Serum

398

1954

2.07

39.58

1.2

1083.08

1159.71

titre

0.09

(3004616) Nuclear Ab [Presence] in Serum

253

1028

2.49

39.55

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

569

3157

1.84

39.50

2.8

2.9

0.28

0.30

g/l

0.36

215

1311

(40767503) Oxygen content in Capillary blood by calculation

395

1943

2.07

39.08

3.3

2.4

16.11

16.09

0.02

225

1015

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

279

1192

2.37

39.07

1.7

1.4

—

(3020891) Body temperature

628

3609

1.78

38.80

5.5

4.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

203

747

2.75

38.79

1.3

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

203

747

2.75

38.79

1.3

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

203

747

2.75

38.79

1.3

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

396

1959

2.06

38.58

1.2

194.33

121.82

titre

0.36

154

(3009466) Valproate [Moles/volume] in Serum or Plasma

282

1224

2.33

38.10

5.1

4.7

363.73

359.48

umol/l

0.17

239

1032

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

456

2386

1.95

37.91

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1126

7566

1.54

37.52

3.1

2.5

66.20

64.03

ml/min/173m2

0.69

483

3012

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

428

2204

1.98

37.28

1.4

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

447

2338

1.95

37.21

1.8

1.9

10.44

11.66

mg/l

2.17

408

2182

(3009508) Creatinine [Moles/volume] in Urine

3808

31527

1.30

36.79

3.3

3.1

7.17

7.38

mmol/l

2.14

3178

26258

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10561

99759

1.40

36.74

5.7

4.9

2.64

2.72

mmol/l

17.47

9639

91241

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

487

2637

1.88

36.51

2.2

2.4

0.00

g/l

0.46

439

2378

(3006184) Hemoglobin [Mass/volume] in Capillary blood

424

2194

1.97

36.42

2.5

2.1

128.73

128.23

g/l

0.14

302

1544

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

481

2598

1.89

36.34

2.2

2.4

0.00

g/l

-0.00

438

2372

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

140

434

3.25

36.25

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

140

434

3.25

36.25

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

235

971

2.45

35.47

1.8

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3830

31850

1.29

35.46

3.9

3.8

8.36

8.55

mg/mmol

0.09

2441

19835

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

158

534

2.98

35.35

1.2

1.3

1.17

1.60

u/ml

0.30

308

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

204

797

2.59

34.66

4.4

5.2

124.79

100.15

u/ml

0.24

247

(3011412) CD3 cells [#/volume] in Blood

200

775

2.61

34.55

2.2

2.3

1.23

1.14

e9/l

0.68

174

701

(3024891) Influenza virus A+B Ag [Presence] in Specimen

409

2129

1.95

34.53

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

405

2117

1.94

33.78

1.6

1.7

28.68

4.54

iu/l

0.47

123

762

(3045424) Erythrocytes [Presence] in Urine

297

1395

2.16

33.20

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

150

511

2.96

33.12

3.2

3.0

—

(3002385) Erythrocyte distribution width [Ratio]

9125

84744

1.29

32.69

27.2

15.5

15.99

15.03

1.29

8996

82957

(3034860) Kappa light chains.free [Mass/volume] in Serum

553

3221

1.75

32.58

3.1

3.3

55.01

57.50

mg/l

0.11

445

2598

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10257

96821

1.35

32.57

5.1

4.4

1.45

1.48

mmol/l

12.26

9336

88425

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

551

3209

1.75

32.48

2.0

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

428

3.13

32.42

1.1

—

(3037756) Immunofixation for Serum or Plasma

402

2127

1.92

32.35

1.4

1.6

—

(3012516) Albumin [Mass/volume] in Urine

3632

30277

1.28

32.27

3.4

3.2

809.77

351.97

mg/l

4.06

2390

18961

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10327

97614

1.35

32.24

5.1

4.4

4.53

4.64

mmol/l

21.75

9459

89618

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

551

3216

1.75

32.23

3.1

3.3

53.33

46.89

mg/l

0.11

442

2590

(3000330) Specific gravity of Urine by Test strip

748

4735

1.62

32.15

4.5

3.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

314

1529

2.08

31.96

7.0

5.1

470.09

1016.92

iu/ml

1.19

237

(3004716) Salmonella sp identified in Stool by Organism specific culture

630

3827

1.68

31.84

1.3

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

217

909

2.41

31.83

1.4

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

428

2324

1.87

31.81

2.3

192.81

195.92

0.29

404

2199

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

459

2551

1.83

31.68

2.3

2.1

92.51

91.41

0.49

442

2438

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

536

3128

1.75

31.37

3.0

3.3

2.98

4.04

ratio

0.40

231

(3008037) Lactate [Moles/volume] in Venous blood

386

2042

1.92

31.09

4.2

2.9

1.60

1.65

mmol/l

0.47

380

1987

(3051593) INR in Capillary blood by Coagulation assay

138

466

2.98

30.98

6.4

12.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

151

539

2.82

30.65

2.0

2.4

468.62

513.38

e6/l

0.60

121

455

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

204

847

2.43

30.53

1.4

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

414

2257

1.86

30.40

1.8

1.7

311.67

295.92

mu/l

0.44

371

2057

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

273

1286

2.15

30.32

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

377

1996

1.92

30.29

1.4

11.78

10.51

u/l

0.83

300

1609

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

253

1162

2.20

29.95

2.5

1.9

21.95

26.51

mg/l

0.70

323

(3008898) HLA-B27 [Presence]

429

2379

1.83

29.83

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

395

2137

1.88

29.71

1.5

—

(40768443) Skin Pathology biopsy report

687

4344

1.62

29.63

1.3

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

294

1438

2.07

29.60

2.5

1.8

1.55

1.74

mmol/l

3.37

288

1400

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

144

512

2.83

29.47

2.0

2.5

0.23

0.25

e9/l

0.32

118

451

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

132

449

2.96

29.27

1.3

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

249

1148

2.19

29.21

3.0

2.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

857

5722

1.53

29.18

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

132

450

2.95

29.16

1.3

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

132

451

2.95

29.05

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

427

2385

1.82

29.01

3.9

3.0

1.61

1.58

mg/l

0.20

392

2156

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

164

630

2.62

28.91

1.5

1.3

2.14

2.13

mmol/l

0.01

150

587

(3018405) Lactate [Moles/volume] in Arterial blood

541

3238

1.70

28.90

4.6

3.9

1.33

1.38

mmol/l

0.40

527

3180

(3038515) Glucose [Moles/volume] in Venous blood

366

1952

1.90

28.78

4.3

2.9

7.56

7.71

mmol/l

0.46

361

1908

(3016244) Insulin [Units/volume] in Serum or Plasma

116

370

3.16

28.75

2.8

3.0

20.63

27.67

mu/l

1.33

106

346

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

226

3.82

28.71

1.3

1.2

—

(3016038) Potassium [Moles/volume] in Urine

156

587

2.68

28.66

1.3

1.1

33.44

35.61

mmol/l

0.54

131

500

(3013005) Retinol [Moles/volume] in Serum or Plasma

247

3.66

28.23

1.9

1.6

1.98

2.02

umol/l

0.15

232

(3024928) Oxygen saturation in Venous blood

347

1831

1.92

28.19

3.1

3.0

—

(40761536) Microorganisms panel - Urine sediment

1095

7748

1.45

27.98

5.7

3.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3968

33874

1.25

27.89

5.2

2.35

3.81

ug/l

7.99

3500

30102

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

623

3905

1.63

27.84

3.0

2.8

40.29

47.43

u/ml

0.31

596

3763

(44816559) Phosphatidylethanol [Mass/volume] in Blood

273

1330

2.08

27.80

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

440

2518

1.77

27.57

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

305

1552

1.99

27.55

1.5

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

153

584

2.64

27.35

2.1

2.0

14.98

15.86

0.44

148

563

(3024869) Neuronal Ab [Presence] in Serum

168

4.24

27.34

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

144

534

2.72

27.24

1.4

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

128

446

2.89

27.22

1.7

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

142

524

2.73

27.12

1.4

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

206

908

2.29

26.97

1.6

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

206

908

2.29

26.97

1.6

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

103

320

3.24

26.70

1.2

1.1

570.74

750.52

ng/l

0.13

(1175426) CD3 cells/100 lymphocytes in Blood

154

601

2.58

26.34

2.1

2.0

71.88

71.95

0.02

147

566

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

118

401

2.96

26.26

2.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

309

1614

1.94

25.90

1.9

1.8

4.90

4.98

mmol/24h

0.14

258

1409

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

282

3.35

25.79

2.5

1.5

78.71

99.08

umol/l

0.73

156

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

170

710

2.41

25.20

1.7

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

277

3.34

25.10

1.9

1.5

29.30

30.85

umol/l

0.76

263

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

145

563

2.59

25.08

2.1

2.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

280

1430

1.98

25.07

1.3

1.2

—

(3039000) Anion gap in Blood

369

2064

1.81

24.99

7.6

6.3

11.03

11.21

mmol/l

0.46

340

1840

(3018572) Chloride [Moles/volume] in Blood

369

2065

1.81

24.95

7.6

6.3

104.68

105.23

mmol/l

1.24

340

1841

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

323

1736

1.88

24.85

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

411

2380

1.75

24.74

3.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

109

367

2.99

24.69

1.5

1.7

101.01

99.11

0.19

104

347

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

574

2.56

24.63

1.7

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

280

1440

1.97

24.58

1.4

—

(3044927) Protein electrophoresis panel - Urine

207

956

2.19

24.26

1.1

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

240

1181

2.05

23.85

3.5

2.6

434.33

2502.67

u/ml

1.60

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

123

451

2.74

23.84

3.4

3.8

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

152

620

2.47

23.75

1.9

2.3

17.07

17.45

nmol/l

0.23

141

583

(3017446) Testosterone [Moles/volume] in Serum or Plasma

915

6455

1.45

23.64

2.3

2.1

12.48

12.07

nmol/l

0.72

785

5731

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

188

846

2.24

23.49

2.6

2.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

217

1035

2.12

23.44

2.0

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

423

2516

1.71

23.15

1.7

1.5

0.52

8.82

iu/ml

0.90

579

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

271

1408

1.95

23.12

1.5

1.4

122.25

120.28

u/ml

0.08

332

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

191

873

2.21

22.99

1.8

960.00

1429.68

titre

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

108

378

2.87

22.86

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

160

682

2.36

22.71

1.4

1.2

74.06

65.02

u/ml

0.13

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

157

664

2.38

22.68

1.4

1.2

105.10

81.70

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

260

1341

1.96

22.67

1.3

1.2

268.47

271.95

u/ml

0.07

165

833

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

100

337

2.98

22.65

1.1

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

157

668

2.37

22.38

1.4

1.2

62.21

43.74

u/ml

0.45

(3019420) Tryptase [Mass/volume] in Serum or Plasma

108

383

2.84

22.32

1.4

1.6

6.84

9.13

ug/l

1.05

341

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

214

3.52

22.29

1.5

1.3

142.67

131.54

nmol/l

0.17

156

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

107

378

2.85

22.27

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

457

2815

1.65

21.91

4.8

4.1

3.88

3.91

mmol/l

0.99

450

2792

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

222

3.44

21.80

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

222

3.44

21.80

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

222

3.44

21.80

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

222

3.44

21.80

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

321

2.97

21.44

1.6

1.8

156.16

156.07

0.00

302

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

138

566

2.45

21.35

6.0

6.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

174

3.75

21.23

1.3

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

281

3.11

21.23

1.8

2.0

28.52

29.31

0.18

261

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

145

610

2.39

21.23

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

145

610

2.39

21.23

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

145

611

2.39

21.15

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

199

958

2.09

21.03

3.6

3.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

208

3.48

21.02

1.3

1.2

108.98

114.62

0.76

185

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

209

1032

2.04

20.64

1.4

1.3

30.53

30.45

u/l

0.01

169

846

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.76

20.51

1.9

2.1

15.39

16.57

umol/l

0.25

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

129

524

2.48

20.40

1.1

1.0

293.90

289.97

mg/l

0.21

116

467

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

143

609

2.36

20.39

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

161

3.80

20.35

1.1

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

279

3.06

20.20

1.3

1.4

15.39

15.56

pmol/l

0.10

230

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

166

757

2.21

20.15

1.8

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

178

835

2.15

20.14

2.8

2.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

261

1404

1.88

20.10

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

245

1291

1.92

20.10

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

225

3.30

19.97

1.3

1.2

0.31

0.32

g/l

0.35

179

(40759836) Histone Ab [Presence] in Serum by Immunoblot

142

609

2.35

19.94

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

142

609

2.35

19.94

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

124

500

2.49

19.93

1.8

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

124

500

2.49

19.93

1.8

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

145

630

2.32

19.77

1.4

1.2

2.33

6.08

u/ml

0.89

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

289

2.99

19.64

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

155

699

2.23

19.36

2.1

38.56

37.97

0.18

150

687

(3004809) Band form neutrophils/100 leukocytes in Blood

275

1525

1.82

19.25

3.3

3.5

1.86

1.55

0.66

242

1325

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

213

3.30

18.89

1.1

91.33

86.01

0.54

100

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

153

694

2.22

18.85

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

280

2.98

18.84

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

304

1749

1.76

18.81

2.6

1.5

0.80

0.79

nmol/l

0.11

247

1453

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

227

1194

1.92

18.76

1.1

14.77

10.17

au/ml

—

(40757494) Bilirubin.total [Moles/volume] in Blood

111

438

2.55

18.70

1.8

2.1

20.26

32.44

umol/l

0.48

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

369

2.70

18.70

1.4

2.0

—

(1002224) Polysomnography panel

501

3279

1.55

18.65

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

364

2.71

18.64

1.4

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

364

2.71

18.64

1.4

2.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

196

986

2.00

18.44

1.1

1.51

1.50

g/l

0.05

176

891

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

174

838

2.09

18.43

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

289

2.92

18.43

1.7

2.1

12.28

10.60

0.38

260

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

138

607

2.29

18.32

2.3

2.4

720.78

628.38

e6/l

1.29

132

578

(3032057) Clostridioides difficile [Presence] in Stool

164

3.61

18.30

1.6

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

285

2.93

18.27

3.3

2.1

—

(3014051) Protein [Presence] in Urine by Test strip

374

2299

1.65

18.13

3.1

2.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

209

1084

1.94

18.02

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

413

2607

1.60

17.98

5.6

3.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

214

1120

1.93

17.97

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

481

3146

1.55

17.97

1.4

1.3

26.35

32.47

iu/l

3.88

417

2705

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

146

665

2.21

17.84

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

189

955

1.99

17.58

3.3

3.5

57.43

57.41

0.00

160

792

(3029634) Reagin Ab [Titer] in Serum by VDRL

196

1004

1.97

17.54

2.0

0.40

2.74

titre

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

208

3.23

17.53

1.1

1.2

89.42

87.29

0.13

101

(3051651) Icteric interference index of Serum or Plasma

122

520

2.36

17.43

4.0

3.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

256

2.98

17.33

1.6

1.8

174.68

186.23

0.37

243

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

111

459

2.43

16.98

1.1

—

(3011985) Renin [Units/volume] in Plasma

214

1142

1.89

16.97

1.5

1.4

59.03

57.97

mu/l

0.02

183

1007

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

263

1501

1.77

16.78

1.4

1.3

120.47

119.22

pmol/l

0.02

253

1470

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

189

976

1.95

16.55

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

134

3.74

16.39

1.3

—

(3004451) EKG impression Narrative

102

413

2.48

16.34

1.4

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

239

2.98

16.24

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

197

1040

1.91

16.17

3.5

3.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

135

622

2.18

16.08

1.7

1.8

6.61

5.50

umol/l

0.44

447

(3022493) Free Hemoglobin [Mass/volume] in Plasma

364

2.57

16.00

2.7

4.1

86.16

67.86

mg/l

0.45

262

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

219

1201

1.84

15.97

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

205

3.13

15.94

1.6

1.5

0.35

0.34

ug/l

0.12

123

(3019832) Treponema pallidum Ab [Presence] in Serum

778

5714

1.39

15.94

1.7

1.6

—

(44813793) Dust mix specific IgE antibody measurement

121

537

2.27

15.80

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

237

1336

1.79

15.79

1.1

1.24

1.73

u/ml

0.64

130

661

(3016650) Hepatitis A virus Ab [Presence] in Serum

216

1186

1.84

15.70

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

203

3.11

15.55

1.7

2.1

159.14

530.26

e6/l

0.83

114

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

209

3.07

15.45

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

225

2.99

15.41

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

221

3.00

15.26

1.1

1.2

105.93

102.43

0.26

205

(3020191) Ethanol [Moles/volume] in Serum or Plasma

124

565

2.21

15.21

1.5

1.2

1.30

1.27

promille

0.06

445

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3000

26146

1.19

15.05

1.7

1.6

1.39

1.33

mmol/l

3.16

2549

21784

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

142

686

2.08

15.01

1.7

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

198

1076

1.85

14.90

1.2

1.3

297.58

427.39

pmol/l

0.72

164

917

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

222

2.94

14.54

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

217

2.96

14.50

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

144

709

2.04

14.49

1.6

22.89

22.86

u/ml

0.00

155

(3045683) HLA typing for celiac disease panel - Blood or Tissue

100

425

2.36

14.47

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

3.06

14.38

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

335

2125

1.59

14.37

1.8

1.7

44.32

43.00

nmol/l

0.42

322

2045

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

297

2.64

14.24

3.5

2.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

129

615

2.11

14.15

1.6

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

110

492

2.25

14.15

1.0

1.1

6.83

8.98

iu/ml

0.71

113

(3014148) Varicella zoster virus Ab [Titer] in Serum

172

909

1.90

14.13

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

173

919

1.89

14.00

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

151

766

1.98

14.00

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

301

2.60

13.87

1.3

—

(21494755) Public health laboratory ask at order entry panel

542

7547

0.71

13.84

1.4

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.01

13.83

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

367

2.44

13.79

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

374

2.42

13.71

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

193

1069

1.82

13.70

1.4

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

194

1078

1.81

13.63

1.1

0.97

1.21

u/ml

0.43

102

546

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

206

1168

1.78

13.53

1.2

2.97

3.99

u/ml

1.19

518

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

210

2.91

13.48

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

138

688

2.02

13.45

1.3

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

355

2.43

13.31

1.1

3.25

7.48

u/ml

1.57

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

144

733

1.98

13.24

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

179

984

1.83

13.05

1.1

1.53

4.13

u/ml

3.86

464

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

130

643

2.03

12.97

1.3

1.2

74.64

158.16

titre

2.35

114

(3027231) Wheat IgE Ab [Units/volume] in Serum

118

3.57

12.92

1.0

1.1

0.70

3.22

u/ml

0.56

(40761539) Cells [Type] in Urine sediment by Light microscopy

210

2.87

12.89

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

4.24

12.87

1.0

1.1

0.02

0.33

u/ml

1.14

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.01

12.86

1.2

1.3

27.71

162.37

g/l

0.62

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

121

585

2.08

12.84

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

261

2.65

12.80

40.5

33.7

7.29

ug/l

0.01

236

(3003338) MCHC [Mass/volume]

8651

82481

1.16

12.65

30.1

16.9

331.41

331.95

g/l

6.60

8575

81784

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

268

1665

1.62

12.58

3.7

3.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

332

2170

1.54

12.55

3.5

3.0

0.83

0.81

nmol/l

0.31

267

1671

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

105

485

2.17

12.54

2.7

2.6

40.02

37.84

0.59

262

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

249

1520

1.65

12.54

2.0

1.8

188.41

199.95

pmol/l

0.98

235

1422

(3003434) Protein [Mass/volume] in Pleural fluid

232

1394

1.68

12.42

1.5

1.4

31.62

32.56

g/l

0.59

217

1236

(3000012) Reticulocyte production index

233

1404

1.67

12.34

2.0

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3063

27129

1.17

12.26

4.5

21.99

22.09

0.12

1461

14013

(3006270) Folate [Moles/volume] in Blood

154

824

1.88

12.25

1.2

336.54

344.28

nmol/l

0.18

126

669

(3023430) Cat dander IgE Ab [Units/volume] in Serum

156

839

1.87

12.22

1.1

1.0

5.32

3.08

u/ml

0.77

338

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.47

12.10

1.3

1.1

12.85

12.80

g/l

0.01

(3003694) ABO and Rh group [Type] in Blood

2942

26017

1.17

11.95

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

129

656

1.98

11.95

1.0

273.24

334.64

ng/l

1.97

441

(3023420) DNA double strand Ab [Units/volume] in Serum

165

911

1.82

11.90

1.5

1.4

32.13

32.23

iu/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

206

1214

1.71

11.87

1.2

4.16

4.35

u/ml

0.04

401

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

343

2287

1.51

11.85

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

163

899

1.82

11.80

1.1

1.0

4.47

2.95

u/ml

0.72

419

(3033923) Metanephrine [Moles/time] in 24 hour Urine

161

3.05

11.79

1.1

0.63

0.66

umol/24h

0.13

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

363

2.32

11.79

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

366

2478

1.49

11.75

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

102

3.64

11.73

2.4

1.4

838.74

11110.83

e6/l

0.59

(3025018) Bordetella pertussis Ab [Titer] in Serum

440

2.19

11.72

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

184

2.89

11.59

1.2

275.38

345.96

pmol/l

0.53

134

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

128

657

1.96

11.56

1.0

704.20

711.00

ng/l

0.06

421

(3028308) Erythrocytes [#/volume] in Pleural fluid

194

1134

1.72

11.53

1.4

1.5

45952.28

64531.24

e6/l

0.49

119

661

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.73

11.52

1.8

1.9

49.09

49.07

pmol/l

0.00

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

128

658

1.96

11.51

1.0

37.76

42.72

ng/l

0.90

432

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.68

11.46

1.3

1.6

1.58

2.78

mg/l

0.54

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.68

11.46

1.3

1.6

2.53

3.41

mg/l

0.35

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.68

11.46

1.3

1.6

2.71

1.35

mg/l

0.35

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.68

11.46

1.3

1.6

3.54

4.80

mg/l

0.28

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.68

11.46

1.3

1.6

4.32

2.45

mg/l

0.42

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.68

11.46

1.3

1.6

0.46

1.01

mg/l

0.71

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.68

11.46

1.3

1.6

1.65

2.02

mg/l

0.17

(3052592) Norovirus Ag [Presence] in Stool

180

2.90

11.44

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

266

2.53

11.33

1.8

1.7

1733.17

39379.03

u/ml

0.71

(3002079) Sodium [Moles/time] in 24 hour Urine

364

2.29

11.28

1.1

1.2

137.58

163.12

mmol/24h

2.20

364

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

211

1273

1.67

11.17

1.8

1.9

24.89

23.49

ug/l

0.09

205

1237

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.53

11.15

1.3

1.6

2.48

2.77

mg/l

0.07

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

5.53

11.15

1.0

1.1

1.40

1.09

u/ml

0.08

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

245

2.58

11.12

2.4

3.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

167

2.94

11.09

1.7

1.5

120.64

112.61

ng/l

0.13

167

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

115

578

2.00

11.05

1.4

1.3

12.02

12.93

umol/l

0.73

103

545

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

245

1541

1.60

11.00

1.2

—

(40768806) Pleura Pathology biopsy report

185

1083

1.72

10.96

1.5

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

255

1623

1.58

10.89

2.4

1.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

234

1460

1.61

10.86

1.8

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

175

2.86

10.80

1.4

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

220

1355

1.63

10.77

1.1

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

244

2.55

10.70

2.3

2.6

1.07

1.05

ug/l

0.02

230

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

166

950

1.76

10.67

1.3

1.2

80.03

66.56

u/l

0.26

150

838

(3006922) Hepatitis E virus Ab [Presence] in Serum

478

2.08

10.63

1.1

—

(3033799) Differential panel - Peritoneal fluid

3.59

10.60

1.7

1.2

—

(3036180) Methadone [Presence] in Urine

222

2.62

10.59

1.9

2.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

195

1172

1.67

10.51

1.7

1.5

59.87

60.35

0.06

123

717

(3013247) Albumin in CSF/Albumin in Serum or Plasma

151

2.99

10.49

1.1

1.0

8.99

7.67

mg/g

0.34

144

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

441

2.12

10.47

1.1

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

202

1230

1.65

10.36

1.5

1699.92

2318.63

e6/l

0.51

142

877

(3017569) Oxygen content in Arterial blood

437

2.11

10.32

3.1

2.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

445

2.10

10.24

1.1

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

198

1209

1.65

10.06

1.1

4.57

5.01

u/ml

0.14

110

595

(3021788) Differential panel - Synovial fluid

269

1769

1.53

9.98

1.6

1.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

142

793

1.80

9.95

2.1

2.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

404

2.14

9.94

14.7

11.6

0.66

0.64

mmol/l

0.43

362

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

321

2.28

9.92

1.3

3.87

4.25

umol/l

0.42

300

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.48

9.86

2.1

2.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

361

2.20

9.79

1.8

1.9

56.60

53.94

ug/l

0.19

353

(3036782) Glucose [Moles/volume] in Pleural fluid

162

946

1.72

9.74

1.4

1.3

6.23

6.31

mmol/l

0.13

152

862

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

428

2.09

9.70

16.4

17.4

12422.33

1417.06

nmol/l

0.49

412

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

128

3.05

9.47

1.2

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

360

2.17

9.45

1.1

2.71

22.42

u/ml

1.07

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

155

2.85

9.44

1.0

1.2

83.63

80.81

—

(3019977) pH of Arterial blood

101

514

1.97

9.44

3.4

2.2

7.41

7.42

0.88

189

(21494890) Protein electrophoresis panel - 24 hour Urine

174

1046

1.67

9.42

1.8

2.1

—

(37021550) Renin [Units/volume] in Plasma --upright

167

2.76

9.34

1.3

81.95

66.44

mu/l

0.13

122

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

362

2.16

9.33

1.6

9.92

3.49

nmol/l

0.61

303

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

111

586

1.90

9.32

1.3

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.35

9.31

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

109

3.22

9.27

1.6

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

577

7478

0.76

9.21

1.8

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.54

9.19

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

112

596

1.89

9.19

1.4

1.3

56.00

63.20

titre

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

188

1161

1.63

9.18

1.1

0.90

1.21

u/ml

0.45

485

(21494814) CD8 cells/100 lymphocytes in Specimen

313

2.24

9.17

2.4

1.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

183

1123

1.64

9.16

39.8

8.3

7.38

7.45

mmol/l

0.08

146

922

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

339

2.19

9.15

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

100

3.31

9.14

2.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

121

3.06

9.05

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1567

13429

1.19

9.03

1.5

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

154

2.80

8.97

1.0

1.2

71.57

75.98

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

115

624

1.85

8.90

1.3

730.00

323.39

titre

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

470

1.99

8.89

1.2

—

(3011288) Drugs identified in Urine by Screen method

213

1368

1.57

8.84

3.6

2.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

294

2.25

8.75

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

299

2069

1.46

8.71

1.3

200.45

216.49

miu/ml

0.31

117

919

(3016879) Cocaine [Presence] in Urine

291

2006

1.46

8.65

2.4

1.8

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.94

8.58

1.1

1.2

—

mmol/l

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

316

2.19

8.56

2.4

2.9

28.53

28.01

umol/l

0.16

241

(3008536) Aspergillus sp Ab [Presence] in Serum

164

2.69

8.53

1.5

2.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

8.46

1.2

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.16

8.44

1.1

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.88

8.40

4.3

3.0

55.67

83.03

pmol/l

0.16

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

110

600

1.84

8.40

3.0

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

339

2.13

8.35

1.1

1415.24

1556.77

miu/ml

0.46

339

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

440

1.98

8.33

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

440

1.98

8.33

1.3

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.38

8.32

2.3

1.3

75273.86

9032.31

e6/l

0.42

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

104

560

1.86

8.28

1.4

1.2

132.29

81.70

u/l

1.52

478

(3010375) cycloSPORINE [Mass/volume] in Blood

289

2.22

8.24

36.2

25.5

135.02

112.29

ug/l

1.38

246

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

179

1125

1.60

8.19

1.1

118.30

117.81

0.07

163

991

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.21

8.18

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

216

2.41

8.11

5.4

4.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

391

2.03

8.05

1.1

0.56

1.73

u/ml

0.88

125

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

362

2631

1.39

8.05

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

172

1076

1.61

8.03

2.0

2.4

0.86

1.24

g/24h

1.47

504

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.26

7.99

1.1

1.2

—

(3018133) Calcium [Moles/volume] in Urine

131

2.83

7.92

1.6

2.2

2.55

2.71

mmol/l

0.19

120

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

127

738

1.73

7.87

1.6

1.2

1.36

1.41

nmol/l

0.22

112

654

(3008116) Ketones [Moles/volume] in Urine by Test strip

154

2.67

7.86

1.5

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.38

7.78

1.1

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1171

9913

1.20

7.71

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

179

2.52

7.70

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

369

4965

0.74

7.69

1.5

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

183

1175

1.57

7.67

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

162

2.60

7.66

1.1

2.95

5.62

pmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

248

2.26

7.58

1.5

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

280

2.18

7.58

1.3

1.2

38.62

41.04

g/l

0.44

149

(3012565) Volume of 24 hour Urine

465

1.90

7.46

1.9

2.1

1955.71

1957.79

0.01

393

(3042111) Morphology [Interpretation] in Bone marrow Narrative

236

1611

1.47

7.44

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

337

2454

1.38

7.44

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

142

2.68

7.38

1.7

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

303

2172

1.40

7.34

2.4

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

248

2.22

7.16

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

552

1.80

7.11

1.4

1.2

28.39

22.02

u/l

0.78

461

(3027923) C peptide [Moles/volume] in Serum or Plasma

445

1.89

7.09

1.4

1.07

1.23

nmol/l

0.73

350

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

128

769

1.67

7.07

1.9

1.8

3.55

4.15

mg/l

1.14

122

730

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.05

7.06

1.2

1.4

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.05

7.06

1.1

1.07

1.18

u/field

0.40

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

143

885

1.62

7.03

1.1

—

(3011648) Oxygen content in Venous blood

110

635

1.74

7.03

2.9

2.4

10.13

11.06

1.46

110

635

(3000475) Leukocytes [#/volume] in Synovial fluid

321

2344

1.38

6.99

1.6

14114.33

14112.86

e6/l

0.00

231

1678

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

361

2689

1.35

6.94

1.9

1.7

—

(3028300) Cannabinoids [Presence] in Urine

303

2198

1.39

6.88

2.4

1.8

—

(3027008) Opiates [Presence] in Urine

302

2193

1.39

6.82

2.4

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

3.25

6.81

1.2

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

355

1.98

6.74

1.4

59.40

64.42

0.56

296

(3015076) Soybean IgE Ab [Units/volume] in Serum

335

2.01

6.71

1.1

1.0

0.44

2.90

u/ml

0.73

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2178

19551

1.14

6.71

3.1

0.68

0.81

ug/l

8.69

1519

13497

(3043410) Blood group antigens tested for on Red Blood Cells

223

2.25

6.70

1.9

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

193

1294

1.50

6.70

1.1

113.98

521.24

iu/ml

0.70

272

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

217

2.26

6.68

1.3

1.5

73.88

72.11

0.37

209

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

124

752

1.66

6.63

1.3

10.12

12.85

u/l

2.15

119

700

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

3.04

6.60

1.2

1.1

0.05

2.90

u/ml

1.28

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

805

6674

1.22

6.60

1.5

1.3

—

(3044007) Cell count panel - Peritoneal fluid

3.10

6.57

2.3

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

457

1.84

6.57

1.1

1.2

1.07

ratio

0.03

158

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

457

1.84

6.57

1.1

1.2

—

(3003129) Base excess in Capillary blood by calculation

238

2.19

6.56

1.8

1.9

1.68

0.61

mmol/l

1.21

223

(3045788) Cell count panel - Pleural fluid

151

965

1.57

6.53

1.4

1.5

—

(3035880) pH of Pleural fluid

555

1.75

6.43

1.3

—

(3020491) Glucose [Moles/volume] in Blood

110

653

1.69

6.40

1.8

2.0

6.97

6.91

mmol/l

0.07

450

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

228

2.20

6.38

1.2

2.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

469

1.82

6.37

1.7

1.4

3.74

2.57

0.36

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.97

6.36

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

6.53

6.32

1.5

1.3

0.77

1.35

umol/24h

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

276

2.07

6.25

2.6

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

109

650

1.68

6.24

3.2

2.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

156

2.44

6.16

1.3

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

3.96

6.15

1.0

0.02

0.26

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

119

733

1.63

6.03

1.1

1.0

0.15

0.41

u/ml

0.82

197

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

105

2.77

6.03

1.3

1.5

0.26

0.12

nmol/l

0.96

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

2.80

5.97

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

302

1.99

5.95

1.1

1.2

0.18

0.30

g/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

379

1.88

5.93

2.6

2.2

50.87

54.55

umol/l

0.35

318

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

129

816

1.59

5.88

1.9

2.1

2.09

2.22

u/field

0.08

316

(3029075) Extractable nuclear Ab panel - Serum

243

2.10

5.86

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

244

2.09

5.80

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

3.78

5.80

1.0

0.03

1.07

u/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

103

619

1.67

5.77

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

212

2.17

5.75

1.3

1.5

538.22

527.98

mu/l

0.03

204

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.23

5.71

1.0

1.1

24.76

10.77

u/l

0.45

(4034850) Laboratory test

393

3053

1.30

5.70

13.6

9.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

321

1.94

5.69

7.6

6.5

25.41

24.90

mmol/l

0.39

282

(3048879) Bone marrow aspiration report

301

1.96

5.65

1.4

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

379

1.85

5.62

1.1

1.0

2.75

0.79

u/ml

0.45

(3001893) Eosinophils/100 leukocytes in Pleural fluid

309

1.95

5.60

1.4

2.48

2.66

0.06

262

(3030313) Adrenal Ab [Titer] in Serum

3.53

5.59

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

115

717

1.61

5.59

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

257

2.03

5.45

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

131

848

1.55

5.44

1.2

1.1

94.28

96.16

0.36

121

776

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.95

5.40

1.3

1.1

12.17

17.53

iu/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.81

5.39

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

326

2494

1.32

5.33

2.2

2.3

103.92

106.97

ug/min

0.04

183

1455

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

113

2.57

5.28

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

102

2.65

5.22

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

448

1.75

5.19

1.1

23.41

26.21

u/l

0.18

399

(40757373) Influenza virus identified in Isolate

176

2.22

5.17

1.5

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

4.58

5.16

1.4

0.14

0.22

u/l

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

449

1.74

5.15

1.1

86.87

84.71

u/l

0.08

403

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

103

2.62

5.13

1.3

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.79

5.13

1.3

1.6

51.63

44.23

umol/l

0.59

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

465

1.73

5.11

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.69

4.98

1.1

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

267

1.95

4.94

1.3

1.2

16.79

133.25

ug/l

2.19

145

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

295

1.90

4.94

2.1

2.4

159.04

154.18

nmol/l

0.12

257

(3042517) Benzodiazepines panel - Urine

3.66

4.91

1.4

2.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.48

4.88

1.0

0.03

0.24

u/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

130

2.39

4.87

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

194

2.12

4.86

1.2

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

228

2.02

4.83

1.5

1.8

17.19

35.03

u/l

1.11

210

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.70

4.83

1.5

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.74

4.76

1.1

—

(3024471) HLA-A [Type]

243

1.98

4.76

1.0

—

(3024316) Viscosity of Plasma

3.57

4.76

1.7

1.5

1.66

1.64

mpas

—

(3002619) Bacteria identified in Specimen by Culture

183

2.13

4.73

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

132

2.35

4.72

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

108

2.50

4.69

1.3

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

114

2.46

4.69

1.1

1.3

37.83

53.09

0.83

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.02

4.66

1.1

1.2

50.50

26.94

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

127

2.37

4.63

1.6

1.4

—

(3017704) Immunofixation for Urine

548

1.63

4.62

1.3

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

564

1.62

4.61

1.6

8.63

5.65

u/l

1.03

451

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.21

4.60

1.0

—

(3047189) Immunofixation for 24 hour Urine

465

1.68

4.59

1.4

1.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

137

932

1.48

4.57

1.7

1.5

25.09

29.59

0.90

561

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.61

4.55

1.8

2.8

—

(3027944) Amphetamines [Presence] in Urine

281

2160

1.31

4.50

2.0

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

2.86

4.48

1.3

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

147

1019

1.45

4.47

1.3

1.4

0.50

0.33

nmol/l

0.67

109

771

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.27

4.46

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

181

2.10

4.46

1.9

2.7

7.70

7.94

mmol/l

0.11

(3044242) Glucose [Moles/volume] in Arterial blood

454

1.68

4.45

3.8

1.8

—

(3024932) HLA-DR beta [Type]

236

1.95

4.42

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

524

1.63

4.41

1.5

1.9

2.59

2.87

u/field

0.13

363

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

183

2.08

4.34

1.1

1.0

5.64

12.04

u/ml

1.17

102

(44786800) Granulocytes/100 leukocytes in Body fluid

113

2.39

4.29

1.3

25.78

22.41

0.17

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.59

4.29

1.1

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

11.67

4.27

3.6

7.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

152

2.17

4.22

2.0

2.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

461

1.65

4.22

1.1

—

(1761868) Lipid panel - Serum or Plasma

3080

32862

0.92

4.20

3.2

2.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.89

4.12

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

148

2.17

4.07

1.3

1.4

9.75

12.42

0.29

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

8.00

4.05

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.86

4.05

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

266

1.85

4.01

1.0

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

111

2.35

3.98

4.2

5.4

71.52

43.16

ug/min

0.94

(3019174) dRVVT (LA screen)

2.82

3.95

1.1

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

275

1.82

3.94

1.4

29.22

20.38

1.24

252

(4146454) Self-monitoring of blood glucose

158

1140

1.39

3.90

2.6

2.8

—

(40768795) Lymph node Pathology biopsy report

142

1010

1.41

3.81

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

186

1.99

3.81

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

286

2259

1.27

3.78

4.5

3.1

27.31

29.63

mg/l

0.47

165

1453

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.91

3.73

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

253

1.82

3.65

1.1

1.3

—

29.03

—

(3044941) Cell count panel - Synovial fluid

200

1515

1.33

3.64

1.4

—

(3040893) Potassium [Moles/volume] in Capillary blood

4.23

3.50

4.5

2.5

4.28

4.22

mmol/l

0.13

(21494434) Karyotype in Bone marrow

120

846

1.42

3.43

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

281

1.75

3.41

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.39

3.38

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.72

3.34

2.9

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

336

1.67

3.32

1.0

1.1

99.87

92.60

0.65

262

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.35

3.30

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.42

3.30

1.1

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.41

3.29

2.1

2.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

233

1.81

3.27

1.4

1.3

37.77

36.33

0.09

160

(3012989) Citrate [Moles/time] in 24 hour Urine

8.57

3.26

2.2

1.7

1.50

2.00

mmol/24h

—

(4281824) Cell count and differential, peritoneal fluid

109

766

1.43

3.20

1.2

1.0

—

(3045142) Bone marrow Pathology biopsy report

145

1070

1.36

3.19

1.3

—

(40765096) Chromosome analysis panel by Banding

287

1.71

3.19

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.86

3.18

1.0

1.1

0.01

1.65

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

144

1065

1.36

3.13

1.1

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

186

1.88

3.13

1.2

1.1

6.64

2.03

u/ml

0.37

100

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

100

695

1.44

3.12

1.4

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

7.50

3.05

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.43

3.04

1.0

1.1

1.48

1.69

umol/24h

0.69

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

255

1.73

2.99

7.0

5.5

70.50

71.59

0.11

205

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.35

2.97

4.4

2.4

1.03

1.13

mmol/l

0.10

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1273

0.70

2.94

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1271

0.70

2.92

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.71

2.91

1.1

1.2

—

mmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1270

0.70

2.91

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1092

0.68

2.90

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.44

2.89

3.1

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.09

2.88

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1267

0.70

2.87

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1372

0.71

2.87

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

289

1.66

2.86

1.1

—

(40768446) Kidney Pathology biopsy report

320

1.63

2.85

1.7

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1060

0.68

2.80

1.5

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.45

2.79

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

232

1.73

2.74

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

233

1.72

2.70

1.3

28.21

21.98

0.60

197

(3000285) Sodium [Moles/volume] in Blood

119

2.02

2.65

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

202

1611

1.26

2.59

1.4

1.3

46.75

37.96

u/l

0.20

178

1365

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.67

2.59

1.0

2.29

2.87

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

127

1.97

2.59

14.2

10.1

4.89

5.64

mmol/l

1.18

127

(3005033) Fetal Nuchal fold Thickness US

1054

0.69

2.59

1.5

1.4

—

(40768441) Liver Pathology biopsy report

506

1.47

2.58

1.2

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

7.14

2.55

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

215

1.72

2.54

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.13

2.54

1.3

1.2

5.52

6.58

mmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

136

1.91

2.49

1.6

1.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.38

2.45

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.67

2.44

1.0

0.38

1.03

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

264

1.63

2.43

2.0

1.9

—

(3016750) Collection duration of Urine

588

1.41

2.42

2.0

2.1

498.65

497.61

min

0.03

438

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.90

2.41

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

6.25

2.37

1.6

2.0

—

(3020650) Glucose [Presence] in Urine

205

1.71

2.36

1.6

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.82

2.34

2.6

4.9

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

364

1.51

2.28

1.2

1.1

278.06

157.74

iu/ml

0.70

357

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.62

2.27

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.22

2.27

2.5

2.7

—

(40768800) Prostate Pathology biopsy report

189

2333

0.81

2.27

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

113

1.95

2.24

1.1

1.4

6.43

136851.15

nmol/l

0.77

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

142

1.83

2.22

1.9

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

194

1.70

2.21

1.8

1.7

9.74

9.51

mg/l

0.08

159

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.86

2.20

1.1

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

361

1.50

2.16

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

101

1.98

2.14

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

116

1.90

2.10

1.7

—

(3013762) Body weight Measured

3.20

2.09

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

254

1.58

2.02

1.1

—

(3034426) Prothrombin time (PT)

270

1.56

2.02

1.1

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.08

2.01

1.3

677.72

525.77

nmol/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

194

2347

0.82

1.96

1.5

—

(36303858) Crystals [Presence] in Urine

3.75

1.93

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.18

1.88

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.17

1.82

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.57

1.80

1.1

1.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.76

1.79

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

107

833

1.29

1.78

2.0

2.2

687.30

641.29

0.54

564

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

329

2862

1.15

1.78

1.5

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

2.03

1.74

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

447

1.39

1.73

1.2

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.85

1.71

1.4

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

250

1.52

1.69

1.8

1.6

9.31

8.63

ug/l

0.48

250

(3006462) Nitrate [Presence] in Urine

466

1.38

1.69

4.2

3.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.16

1.66

1.3

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.58

1.65

1.0

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

244

1.52

1.64

9.6

7.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.25

1.63

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.14

1.60

1.0

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.95

1.58

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.00

1.58

4.9

5.8

55.84

76.83

g/mol

0.34

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.27

1.55

1.0

—

(3017509) Phencyclidine [Presence] in Urine

2.03

1.53

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

184

1.58

1.53

1.0

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

138

1.67

1.51

1.1

1.2

191.98

130.58

ng/l

0.20

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.00

1.48

5.5

8.9

—

(3000034) Microalbumin [Mass/volume] in Urine

115

931

1.24

1.44

3.3

2.9

52.72

46.46

mg/l

0.08

674

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

125

1.68

1.43

1.5

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

196

1.53

1.42

1.3

1.2

177.83

32.40

mg/l

0.37

155

(46235168) Fasting glucose [Moles/volume] in Blood

103

1.75

1.40

3.5

3.3

7.33

7.99

mmol/l

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

111

1.71

1.38

7.6

5.3

—

(3014891) Appearance of Pleural fluid

142

1.62

1.38

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

158

1.58

1.37

2.0

3.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

130

1562

0.83

1.33

1.5

1.4

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.50

1.30

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

437

1.33

1.30

2.7

3.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

116

958

1.21

1.24

3.8

3.5

22.78

46.69

u/ml

4.15

116

949

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.22

1.24

1.0

1.3

348.00

279.86

umol/24h

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

110

905

1.22

1.23

1.3

1.4

43080.99

120521.81

e6/l

2.05

636

(3042010) Triglyceride [Moles/volume] in Pleural fluid

131

1.60

1.23

1.4

1.2

1.25

1.51

mmol/l

0.12

(3041918) Cholesterol [Moles/volume] in Pleural fluid

171

1.52

1.22

1.3

1.2

1.78

1.56

mmol/l

0.42

103

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.63

1.21

1.0

2.8

1.48

3.05

mu/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

205

1.46

1.19

7.2

7.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.83

1.19

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.31

1.18

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

256

1.41

1.17

1.5

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

207

1.45

1.14

1.2

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

2.33

1.12

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.00

1.12

1.0

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

1.90

1.12

1.4

1.1

—

(3022689) Creatine [Moles/volume] in Urine

284

1.37

1.12

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.82

1.08

1.2

1.7

—

(3010937) Rubella virus Ab [Presence] in Serum

1.95

1.08

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.95

1.08

1.3

4.3

—

0.00

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

335

3030

1.11

1.08

1.7

1.6

5.19

3.42

mg/l

1.17

243

2170

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.92

1.06

1.1

1.3

1.00

1.28

u/field

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.27

1.03

3.8

2.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.63

1.03

1.1

1.0

104.46

82.37

ug/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.06

1.02

11.9

12.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

106

0.47

1.00

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

449

1.27

0.98

6.7

4.7

869.30

9343.11

u/ml

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.80

0.96

1.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

100

1.60

0.96

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.69

0.95

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

135

1.48

0.88

1.9

2.7

0.55

0.52

u/field

0.05

135

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.79

0.87

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

237

1.35

0.87

1.2

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.86

0.87

1.0

8.28

8.41

mmol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

311

0.71

0.86

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.94

0.84

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.78

0.84

6.3

6.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.78

0.84

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

283

1.31

0.83

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

562

1.21

0.81

1.3

1.58

1.56

g/l

0.16

562

(40768793) Breast Pathology biopsy report

248

2255

1.10

0.79

1.4

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.67

0.78

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

848

0.84

0.78

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.62

0.78

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

123

1.46

0.77

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

123

1.46

0.77

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

123

1.46

0.77

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

278

1.30

0.77

3.4

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

278

1.30

0.77

3.4

2.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.70

0.75

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

421

3929

1.07

0.75

1.8

1.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.08

0.74

3.8

2.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.64

0.73

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.00

0.72

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.64

0.68

1.0

1.1

—

(3008607) Semen analysis panel

1.79

0.66

1.4

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.61

0.65

1.7

2.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

708

1.16

0.64

1.3

1.4

5.71

3.79

ug/l

0.27

600

(3015183) Erythrocyte sedimentation rate

359

1.23

0.63

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

112

1.43

0.63

1.6

1.5

—

(3024263) Appearance of Synovial fluid

534

1.18

0.62

1.2

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.67

0.61

1.2

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.15

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.54

0.59

5.9

5.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.53

0.59

1.4

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

140

1.36

0.58

1.3

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.45

0.56

1.1

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

100

1125

0.89

0.56

1.5

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.44

0.55

1.7

1.2

6.35

9.18

mg/l

0.63

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

159

1.32

0.55

5.6

6.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

172

1.28

0.48

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

181

1.27

0.47

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

142

1543

0.92

0.44

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

202

1.24

0.43

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

119

1087

1.10

0.43

1.2

1.1

—

(40763590) HLA-DQ beta [Type]

1.61

0.43

1.0

—

(40760410) HLA-B [Type] by High resolution

1.61

0.43

1.0

—

(40760409) HLA-A [Type] by High resolution

1.61

0.43

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.61

0.43

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

1.61

0.43

1.0

—

(3013862) HLA-DP [Type]

1.56

0.42

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.52

0.41

1.0

—

(3025130) Human papilloma virus identified in Specimen

118

1082

1.09

0.40

1.5

1.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.38

0.38

1.6

2.9

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.39

0.38

1.4

1.2

1.28

1.32

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

600

1.12

0.37

1.4

1.3

144.68

178.75

pmol/l

1.01

600

(3002523) Influenza virus A Ag [Presence] in Specimen

118

1088

1.09

0.37

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.27

0.36

1.1

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

124

0.73

0.35

7.3

7.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

509

1.12

0.34

2.0

2.2

67.83

106.89

ug/min

0.38

122

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.31

0.30

1.2

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

118

0.76

0.27

2.9

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

118

0.76

0.27

5.8

6.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

570

0.91

0.24

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

413

0.90

0.24

1.2

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

180

1.17

0.23

2.6

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.32

0.23

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.22

1.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.19

0.21

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.16

0.21

6.6

8.3

149.60

461.29

e6/l

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.25

0.20

1.5

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

101

1.19

0.16

1.0

—

(4212803) Bone marrow aspirate examination

111

1.17

0.15

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

842

0.95

0.15

1.5

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

188

1.12

0.14

4.2

6.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1013

0.96

0.14

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

168

0.89

0.11

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

146

0.89

0.10

1.8

2.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

125

1215

1.03

0.10

1.2

1.3

7.38

7.44

mmol/l

0.09

112

1060

(40758358) Immune stain study

1.11

0.09

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.05

0.07

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

712

0.97

0.07

2.2

1.9

4.43

3.61

ug/l

0.42

646

(40762814) Titanium [Mass/volume] in Blood

196

1.07

0.07

2.0

2.2

2.56

3.43

ug/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

118

1.10

0.07

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

214

0.93

0.07

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.10

0.04

2.5

5.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

167

1688

0.99

0.03

3.9

3.6

56.22

34.95

u/ml

0.47

162

1633

(40758292) HTLV I+II Ab panel - Serum

141

1.06

0.03

1.3

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

182

1.04

0.02

1.4

1.7

1.66

2.17

ug/l

—

107

(3001729) Color of Synovial fluid

1.06

0.01

1.2

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

215

0.98

0.00

5.0

1.3

—

(3025577) Chromium [Mass/volume] in Blood

699

1.00

0.00

2.2

2.0

2.51

2.24

ug/l

0.27

586

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.01

0.00

1.7

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

15.08

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

158.33

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3006840) Garlic IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.12

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.88

-0.00

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

162.67

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.43

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.93

-0.00

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.00

-0.00

4.0

2.9

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_DYSPHAGIA – Dysphagia

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dysphagia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Dysphagia (R18_DYSPHAGIA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints